30th Apr 2021 07:00
Barclays PLC
Q1 2021 Results Announcement
31 March 2021
Performance Highlights
Barclays continues to benefit from its diversified business model, whilst supporting the economy through the COVID-19 pandemic
Barclays delivered a record quarterly Group profit before tax in Q121 of £2.4bn1 (Q120: £0.9bn), attributable profit of £1.7bn (Q120: £0.6bn), a return on tangible equity (RoTE) of 14.7% (Q120: 5.1%) and earnings per share (EPS) of 9.9p (Q120: 3.5p)
Income
Diversified income streams with strong CIB income partially offsetting challenges in Barclays UK and CC&P | Group income of £5.9bn down 6% versus prior year | ||
· | Barclays International income of £4.4bn, down 5% versus prior year | ||
- | Corporate and Investment Bank (CIB) income of £3.6bn, down 1% with Equities and Banking up 65% and 35% respectively, whilst FICC was down 35% versus a very strong Q120 comparative | ||
- | Consumer, Cards and Payments (CC&P) income of £0.8bn, down 22% due to lower cards balances and reduced payments activity | ||
· | Barclays UK income of £1.6bn, down 8% versus prior year reflecting deposit margin compression from lower interest rates and lower interest earning lending (IEL) balances, partially offset by strong mortgages performance with record quarterly organic net asset growth of £3.6bn to £151.9bn | ||
Credit impairment charges
Reduced impairment as underlying asset quality metrics remained benign | Group credit impairment charges decreased significantly to £0.1bn (Q120: £2.1bn) | ||
· | The low credit impairment charge was driven by reduced unsecured lending balances, no material single name wholesale loan charges and limited portfolio deterioration | ||
· | Total balance sheet impairment allowance of £8.8bn (FY20: £9.4bn), resulting in broadly stable coverage ratios for unsecured consumer lending and wholesale portfolios of 12.2% (FY20: 12.3%) and 1.4% (FY20: 1.5%) respectively | ||
Costs
Cost: income ratio of 61% | Group total operating expenses of £3.6bn up 10% versus prior year | ||
· | Total operating expenses include higher variable compensation accruals reflective of improved returns and continued investment in businesses, partially offset by foreign exchange movements and efficiency savings, resulting in a cost: income ratio of 61% (Q120: 52%). COVID-19 related expenses continued in Q121 | ||
Capital / capital distributions
Strong capital position and completed share buyback | Common equity tier 1 (CET1) ratio of 14.6% down 50bps versus FY20 | ||
· | The decrease reflects profit before tax more than offset by reversal of certain regulatory forbearance measures applied through 2020, the impact of the share buyback announced with FY20 results, a dividend accrual, and an increase in Risk Weighted Assets (RWAs), principally in the CIB | ||
· | In April, completed £0.7bn share buyback announced with FY20 results | ||
1 | Since Q308 which included material adjusting items. |
Group outlook and targets
Outlook Remains uncertain and subject to change depending on the evolution and persistence of the COVID-19 pandemic
| Returns | |
· | Barclays expects to deliver meaningful year-on-year RoTE improvement in 2021 | |
Income | ||
· | Headwinds to income in Barclays UK are expected to persist in 2021, driven by the subdued demand for unsecured lending and the low interest rate environment, partially offset by the recent steepening of the yield curve | |
· | Within Barclays International, the CIB franchise remains well positioned for the future; CC&P income outlook remains uncertain, despite early signs of an anticipated spending recovery in the US and UK, with US cards balances expected to start to recover later in the year | |
Impairment | ||
· | Barclays expects that the full year 2021 impairment charge will be materially below that of 2020 reflecting delinquency experience and an improved economic outlook during the latter part of Q121. If these conditions persist, Barclays would expect to reduce the impairment provision level | |
Costs | ||
· | Barclays expects full year 2021 costs to be above 2020, reflecting investment in the Group's franchises for future returns including higher variable compensation and further structural cost actions, with a real estate review expected to be concluded in the coming months. COVID-19 related expenses are also expected to remain in 2021 | |
Capital | ||
· | Barclays remains in a strong capital position, although certain headwinds are likely in 2021, including the expected reversal of software amortisation benefit applied in 2020 and scheduled pension deficit reduction contributions | |
Targets | Barclays continues to target the following over the medium term: | |
· | Returns: RoTE of greater than 10% over time | |
· | Cost efficiency: Cost: income ratio below 60% over time | |
· | Capital adequacy: CET1 ratio in the range of 13-14% | |
Barclays Group results | |||
for the three months ended | 31.03.21 | 31.03.20 | |
£m | £m | % Change | |
Net interest income | 1,851 | 2,331 | (21) |
Net fee, commission and other income | 4,049 | 3,952 | 2 |
Total income | 5,900 | 6,283 | (6) |
Credit impairment charges | (55) | (2,115) | 97 |
Net operating income | 5,845 | 4,168 | 40 |
Operating expenses | (3,545) | (3,253) | (9) |
Litigation and conduct | (33) | (10) | |
Total operating expenses | (3,578) | (3,263) | (10) |
Other net income | 132 | 8 | |
Profit before tax | 2,399 | 913 | |
Tax charge | (496) | (71) | |
Profit after tax | 1,903 | 842 | |
Non-controlling interests | (4) | (16) | 75 |
Other equity instrument holders | (195) | (221) | 12 |
Attributable profit | 1,704 | 605 | |
Performance measures | |||
Return on average tangible shareholders' equity | 14.7% | 5.1% | |
Average tangible shareholders' equity (£bn) | 46.5 | 47.0 | |
Cost: income ratio | 61% | 52% | |
Loan loss rate (bps) | 6 | 223 | |
Basic earnings per share | 9.9p | 3.5p | |
As at 31.03.21 | As at 31.12.20 | As at 31.03.20 | |
Balance sheet and capital management1 | £bn | £bn | £bn |
Loans and advances at amortised cost | 345.8 | 342.6 | 374.1 |
Loans and advances at amortised cost impairment coverage ratio | 2.2% | 2.4% | 2.1% |
Deposits at amortised cost | 498.8 | 481.0 | 470.7 |
Tangible net asset value per share | 267p | 269p | 284p |
Common equity tier 1 ratio | 14.6% | 15.1% | 13.1% |
Common equity tier 1 capital | 45.9 | 46.3 | 42.5 |
Risk weighted assets | 313.4 | 306.2 | 325.6 |
Average UK leverage ratio | 4.9% | 5.0% | 4.5% |
UK leverage ratio | 5.0% | 5.3% | 4.5% |
Funding and liquidity | |||
Group liquidity pool (£bn) | 290 | 266 | 237 |
Liquidity coverage ratio | 161% | 162% | 155% |
Loan: deposit ratio | 69% | 71% | 79% |
1 | Refer to pages 21 to 26 for further information on how capital, RWAs and leverage are calculated. |
Group Chief Executive Officer's Review
"Since the early days of the pandemic last year, our diversified business has demonstrated the resilience critical to ensuring Barclays' financial integrity. It gives us the capacity to step up for our customers, clients, colleagues and communities when they need our support the most, and deliver for our shareholders by staying profitable in every quarter.
Our diversification continued to drive a strong performance, delivering a Group RoTE of 14.7% in the first quarter of 2021. Group profit before tax increased to £2.4bn, contributing towards EPS of 9.9 pence.
As was the case throughout 2020, within Barclays International, performance in the CIB was strong this quarter, achieving a RoTE of 17.9% on income of £3.6bn, just 1% down from our Q1 income performance last year, which was a very strong comparative.
It also partially offset challenges in our consumer businesses that have been impacted by lower spend and activity levels as a result of the pandemic. Barclays UK generated income of £1.6bn in the quarter with lower impairment charges resulting in a RoTE of 12.0%. Strong demand in mortgages and record completions drove organic net asset growth of £3.6bn which was our best ever single quarter. Our CC&P business generated an income of £805m and delivered a RoTE of 16.5%.
As we enter the next phase of this pandemic, we remain resolute in our commitment to support the economic recovery. From our spend data, which captures UK economic activity across our cards and acquiring businesses, we are already seeing encouraging early signs of recovery in some sectors, including those hit hardest by the crisis.
While momentum in the consumer businesses, particularly card balances, will take time to build, Barclays secured significant new growth opportunities in Q1.
We negotiated a new, long-term agreement to issue Gap's co-branded and private label credit card programme in the US from May 2022.
Following the launch of our point-of-sale finance partnership with Amazon in Germany last year, we have agreed to extend our Amazon partnership to the UK, a significant expansion of our franchise in Europe's two largest consumer markets. Alongside existing partnerships including with Apple in the UK, it demonstrates the strength and potential of our consumer platform.
More broadly across payments, we expect to realise around £900m of income growth opportunity over the coming three years.
While evidence of recovery is encouraging, we have continued to take a cautious view of the impact of the pandemic on the business. We remain disciplined on costs, with a cost to income ratio of 61% this quarter. Our capital position remains well above target with a CET1 ratio of 14.6% and we completed our £700m buyback this month. We will give further guidance on distributions when appropriate.
With a strong balance sheet and diversified business, Barclays remains well-positioned to support the economy and deliver for our shareholders."
James E Staley, Group Chief Executive Officer
Group Finance Director's Review
Q121 performance continued to be impacted by the COVID-19 pandemic. For comparability purposes below, Q120 income in the consumer businesses was largely unaffected by the onset of the pandemic, while our Markets business in the CIB benefitted from increased client activity and volatility towards the end of Q120, resulting in a very strong comparative. Impairment charges were elevated in Q120, reflecting the outlook for the macroeconomic environment at the time.
Group performance
· | RoTE was 14.7% (Q120: 5.1%) and EPS was 9.9p (Q120: 3.5p) |
· | Profit before tax was £2,399m (Q120: £913m) and attributable profit was £1,704m (Q120: £605m). The 8% depreciation of average USD against GBP adversely impacted income and profits and positively impacted credit impairment charges and total operating expenses |
· | Pre-provision profits of £2,454m (Q120: £3,028m) was driven by headwinds in Barclays UK and CC&P, but the Group continues to benefit from its diversified business model, which included a strong performance in CIB |
· | Total income decreased to £5,900m (Q120: £6,283m). Barclays UK income decreased 8%. Barclays International income decreased 5%, with CIB income down 1% and CC&P income down 22% |
· | Credit impairment charges were £55m (Q120: £2,115m). The low credit impairment charge was driven by reduced unsecured lending balances, no material single name wholesale loan charges and limited portfolio deterioration. The reduction in unsecured lending balances and growth in secured balances resulted in a slight decrease in the Group's loans and advances at amortised cost impairment coverage ratio to 2.2% (December 2020: 2.4%) with underlying portfolio ratios broadly stable. Management adjustments to models for impairment have been maintained at £1.2bn (December 2020: £1.4bn), including the economic uncertainty provisions relating to the COVID-19 pandemic that were recognised over the course of 2020 |
· | Total operating expenses increased 10% to £3,578m, due to higher variable compensation accruals that reflect improvement in returns and continued investment in businesses, partially offset by efficiency savings, resulting in a cost: income ratio of 61% (Q120: 52%). COVID-19 related expenses continued in Q121 |
· | The effective tax rate was 20.7% (Q120: 7.8%). The effective tax rate for Q121 was higher than Q120 which reflected the tax benefit recognised for the re-measurement of UK deferred tax assets as a result of the UK corporation tax rate being maintained at 19% |
· | Total assets increased to £1,380bn (December 2020: £1,350bn) primarily due to a £26bn increase in financial assets at fair value due to an increase in secured lending, a £30bn increase in cash deposits and settlement balances, partially offset by a £32bn decrease in derivative assets driven by an increase in major interest rate curves |
· | Tangible net asset value (TNAV) per share decreased to 267p (December 2020: 269p) primarily reflecting negative reserve movements, partially offset by 9.9p of EPS |
Barclays UK
· | Profit before tax increased 136% to £460m. RoTE was 12.0% (Q120: 6.9%) reflecting materially lower credit impairment charges, partially offset by lower income | |
· | Total income decreased 8% to £1,576m. Net interest income reduced 9% to £1,281m with a net interest margin (NIM) of 2.54% (Q120: 2.91%). Net fee, commission and other income increased 1% to £295m | |
- | Personal Banking income decreased 5% to £923m, reflecting deposit margin compression from lower interest rates and lower unsecured lending balances, partially offset by balance growth in deposits and mortgages | |
- | Barclaycard Consumer UK income decreased 28% to £315m as reduced borrowing and spend levels by customers resulted in a lower level of IEL balances | |
- | Business Banking income increased 13% to £338m due to lending and deposit balance growth from continued support for small and medium-sized enterprises (SMEs) through £11.8bn of government scheme lending to date, partially offset by deposit margin compression from lower interest rates and lower transactional fee volumes | |
· | Credit impairment charges decreased to £77m (Q120: £481m) from reduced unsecured portfolio exposures in part driven by lockdown measures. As at 31 March 2021, 30 and 90 day arrears rates in UK cards were 1.6% (Q120: 1.8%) and 0.8% (Q120: 0.8%) respectively | |
· | Total operating expenses increased 1% to £1,039m reflecting higher servicing and financial assistance costs, offset by efficiency savings | |
· | Loans and advances to customers at amortised cost remained stable at £205.7bn (December 2020: £205.4bn) predominantly from £3.6bn of mortgage growth following continued strong demand, offset by a £2.1bn decrease in the Education, Social Housing and Local Authority (ESHLA) portfolio and £1.6bn lower unsecured lending balances | |
· | Customer deposits at amortised cost increased 3% to £247.5bn reflecting an increase of £6.3bn in Personal Banking, further strengthening the liquidity position and contributing to a loan: deposit ratio of 88% (December 2020: 89%) | |
· | RWAs decreased to £72.7bn (December 2020: £73.7bn) driven by a reduction in unsecured lending and ESHLA, partially offset by growth in mortgages | |
Barclays International
· | Profit before tax increased 140% to £1,971m with a RoTE of 17.7% (Q120: 6.8%), reflecting a RoTE of 17.9% (Q120: 12.5%) in CIB and 16.5% (Q120: (23.5)%) in CC&P | ||
· | The 8% depreciation of average USD against GBP adversely impacted income and profits and positively impacted credit impairment charges and total operating expenses | ||
· | Total income decreased to £4,399m (Q120: £4,644m) | ||
- | CIB income decreased 1% to £3,594m | ||
- | Markets income decreased 12% to £2,136m as Equities reported the best ever quarter on a comparable basis1, offset by FICC. Equities income increased 65% to £932m driven by derivatives, reflecting strong client activity, and financing through increased client balances. Within FICC, income decreased 35% to £1,204m as a strong performance in credit was more than offset by a decline in macro due to tighter spreads and the non-recurrence of Q120 client activity levels | ||
- | Banking had the best ever quarter on a comparable basis1, with income up 35% to £859m driven by a strong performance in equity capital markets reflecting an increase in the fee pool2 | ||
- | Within Corporate, Transaction banking income decreased 12% to £393m as deposit balance growth was more than offset by margin compression. Corporate lending income increased by 86% to £206m driven by the non- recurrence of losses on the mark-to-market of lending and related hedge positions | ||
- | CC&P income decreased 22% to £805m reflecting lower cards balances and reduced payments activity | ||
· | Credit impairment charges decreased to a £22m release (Q120: £1,609m charge) | ||
- | CIB credit impairment charge was a £43m release (Q120: £724m charge) due to no material single name wholesale loan charges and lower exposures | ||
- | CC&P credit impairment charges were £21m (Q120: £885m) reflecting lower unsecured lending balances, particularly in US cards. As at 31 March 2021, 30 and 90 day arrears in US cards were 2.1% (Q120: 2.7%) and 1.2% (Q120: 1.5%) respectively | ||
· | Total operating expenses increased 11% to £2,459m | ||
- | CIB total operating expenses increased 12% to £1,887m due to higher variable compensation accruals that reflect improvement in returns, partly offset by cost efficiencies and discipline in the current environment | ||
- | CC&P total operating expenses increased 8% to £572m driven by the impact of higher investment spend and customer remediation costs | ||
· | RWAs increased to £230.0bn (December 2020: £222.3bn) primarily due to increased client and trading activity within CIB, partially offset by lower CC&P balances | ||
Head Office
· | Loss before tax was £32m (Q120: £104m) |
· | Total income was an expense of £75m (Q120: £65m), which primarily reflected hedge accounting, treasury items and funding costs on legacy capital instruments |
· | Total operating expenses increased to £80m (Q120: £16m) primarily due to the non-recurrence of a provision release in Q120, related to the previous sale of a Non-Core portfolio |
· | Other net income was £123m (Q120: £2m) driven by a fair value gain in Barclays' associate investment holding in the Business Growth Fund (BGF) |
1 | Period covering Q114 - Q121. Pre 2014 financials were not restated following re-segmentation in Q116. |
2 | Data source: Dealogic for the period covering 1 January to 31 March 2021. |
Group capital and leverage
· | The CET1 ratio decreased to 14.6% (December 2020: 15.1%) | |
- | CET1 capital decreased by £0.4bn to £45.9bn as profit before tax of £2.4bn was more than offset by the removal of temporary regulatory supporting measures introduced in 2020, the £0.7bn share buyback announced with FY20 results and decreases in other qualifying reserves. The additional value adjustments (PVA) deduction increased by £0.4bn reflecting the removal of increased diversification factors and IFRS 9 transitional relief decreased by £0.3bn primarily due to the relief on the pre-2020 impairment charge reducing from 70% to 50% in 2021. The deduction for dividends paid and foreseen increased by £1.0bn including the £0.7bn share buyback and a £0.1bn accrual towards FY21 dividends | |
- | RWAs increased by £7.2bn to £313.4bn primarily due to increased client and trading activity within CIB, partially offset by lower consumer lending | |
· | The average UK leverage ratio decreased to 4.9% (December 2020: 5.0%). The average leverage exposure increased by £28bn to £1,175bn (December 2020: £1,147bn) largely driven by an increase in securities financing transactions (SFTs) | |
Group funding and liquidity
· | The liquidity pool was £290bn (December 2020: £266bn) and the liquidity coverage ratio remained significantly above the 100% regulatory requirement at 161% (December 2020: 162%), equivalent to a surplus of £107bn (December 2020: £99bn). The increase in the pool is driven by continued deposit growth, Term Funding Scheme with additional incentives for SMEs drawings and a seasonal increase in short-term wholesale funding, which were partly offset by a seasonal increase in business funding consumption |
· | Wholesale funding outstanding, excluding repurchase agreements, was £157.8.bn (December 2020: £145.0bn). The Group issued £2.7bn equivalent of minimum requirement for own funds and eligible liabilities (MREL) instruments from Barclays PLC (the Parent company) during the year. The Group is well advanced in its MREL issuance plans relative to the estimated 1 January 2022 requirement |
Other matters
· | In its Budget held in March 2021, the UK Government announced that the UK rate of corporation tax will increase from 19% to 25% from 1 April 2023 and that it will undertake a review of the additional 8% banking surcharge during 2021. The Budget Report issued on 3 March 2021 outlines that "the government will set out how it intends to ensure that the combined rate of tax on banks' profits does not increase substantially from its current level". The Group's effective tax rate for FY21 may include a tax benefit for the re-measurement of UK deferred tax assets upon substantive enactment of the increase in the rate of UK corporation tax which is expected later in 2021. Any subsequent reduction in the banking surcharge arising from the Government's review may result in a tax charge upon enactment as UK deferred tax assets are again re-measured, the timing of which is uncertain but is expected to occur in 2022 |
Capital distributions
· | Barclays understands the importance of delivering attractive total cash returns to shareholders. Barclays is therefore committed to maintaining an appropriate balance between total cash returns to shareholders, investment in the business and maintaining a strong capital position. Going forward, Barclays intends to pay a progressive ordinary dividend, taking into account these objectives and the earnings outlook of the Group. It is also the Board's intention to continue to supplement the ordinary dividends with additional cash returns, including share buybacks, to shareholders as and when appropriate |
· | For regulatory capital purposes, Barclays has accrued an ordinary dividend in Q121 of 0.75p based on a 3p dividend for the full year. This regulatory accrual should not be used as a forecast of future capital distributions. The Board will assess the appropriate level and form of capital distributions as the year progresses |
Tushar Morzaria, Group Finance Director
Quarterly Results Summary
Barclays Group | ||||||||||
Q121 | Q420 | Q320 | Q220 | Q120 | Q419 | Q319 | Q219 | |||
Income statement information | £m | £m | £m | £m | £m | £m | £m | £m | ||
Net interest income | 1,851 | 1,845 | 2,055 | 1,892 | 2,331 | 2,344 | 2,445 | 2,360 | ||
Net fee, commission and other income | 4,049 | 3,096 | 3,149 | 3,446 | 3,952 | 2,957 | 3,096 | 3,178 | ||
Total income | 5,900 | 4,941 | 5,204 | 5,338 | 6,283 | 5,301 | 5,541 | 5,538 | ||
Credit impairment charges | (55) | (492) | (608) | (1,623) | (2,115) | (523) | (461) | (480) | ||
Net operating income | 5,845 | 4,449 | 4,596 | 3,715 | 4,168 | 4,778 | 5,080 | 5,058 | ||
Operating costs | (3,545) | (3,480) | (3,391) | (3,310) | (3,253) | (3,308) | (3,293) | (3,501) | ||
UK bank levy | - | (299) | - | - | - | (226) | - | - | ||
Litigation and conduct | (33) | (47) | (76) | (20) | (10) | (167) | (1,568) | (53) | ||
Total operating expenses | (3,578) | (3,826) | (3,467) | (3,330) | (3,263) | (3,701) | (4,861) | (3,554) | ||
Other net income/(expenses) | 132 | 23 | 18 | (26) | 8 | 20 | 27 | 27 | ||
Profit before tax | 2,399 | 646 | 1,147 | 359 | 913 | 1,097 | 246 | 1,531 | ||
Tax charge | (496) | (163) | (328) | (42) | (71) | (189) | (269) | (297) | ||
Profit/(loss) after tax | 1,903 | 483 | 819 | 317 | 842 | 908 | (23) | 1,234 | ||
Non-controlling interests | (4) | (37) | (4) | (21) | (16) | (42) | (4) | (17) | ||
Other equity instrument holders | (195) | (226) | (204) | (206) | (221) | (185) | (265) | (183) | ||
Attributable profit/(loss) | 1,704 | 220 | 611 | 90 | 605 | 681 | (292) | 1,034 | ||
Performance measures | ||||||||||
Return on average tangible shareholders' equity | 14.7% | 1.8% | 5.1% | 0.7% | 5.1% | 5.9% | (2.4%) | 9.0% | ||
Average tangible shareholders' equity (£bn) | 46.5 | 47.6 | 48.3 | 50.2 | 47.0 | 46.4 | 48.4 | 46.2 | ||
Cost: income ratio | 61% | 77% | 67% | 62% | 52% | 70% | 88% | 64% | ||
Loan loss rate (bps) | 6 | 56 | 69 | 179 | 223 | 60 | 52 | 56 | ||
Basic earnings/(loss) per share | 9.9p | 1.3p | 3.5p | 0.5p | 3.5p | 3.9p | (1.7p) | 6.0p | ||
Balance sheet and capital management1 | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | ||
Loans and advances at amortised cost | 345.8 | 342.6 | 344.4 | 354.9 | 374.1 | 339.1 | 345.1 | 339.3 | ||
Loans and advances at amortised cost impairment coverage ratio | 2.2% | 2.4% | 2.5% | 2.5% | 2.1% | 1.8% | 1.9% | 1.9% | ||
Total assets | 1,379.7 | 1,349.5 | 1,421.7 | 1,385.1 | 1,444.3 | 1,140.2 | 1,290.4 | 1,232.8 | ||
Deposits at amortised cost | 498.8 | 481.0 | 494.6 | 466.9 | 470.7 | 415.8 | 420.6 | 413.6 | ||
Tangible net asset value per share | 267p | 269p | 275p | 284p | 284p | 262p | 274p | 275p | ||
Common equity tier 1 ratio | 14.6% | 15.1% | 14.6% | 14.2% | 13.1% | 13.8% | 13.4% | 13.4% | ||
Common equity tier 1 capital | 45.9 | 46.3 | 45.5 | 45.4 | 42.5 | 40.8 | 41.9 | 42.9 | ||
Risk weighted assets | 313.4 | 306.2 | 310.7 | 319.0 | 325.6 | 295.1 | 313.3 | 319.1 | ||
Average UK leverage ratio | 4.9% | 5.0% | 5.1% | 4.7% | 4.5% | 4.5% | 4.6% | 4.7% | ||
Average UK leverage exposure | 1,174.9 | 1,146.9 | 1,111.1 | 1,148.7 | 1,176.2 | 1,142.8 | 1,171.2 | 1,134.6 | ||
UK leverage ratio | 5.0% | 5.3% | 5.2% | 5.2% | 4.5% | 5.1% | 4.8% | 5.1% | ||
UK leverage exposure | 1,145.4 | 1,090.9 | 1,095.1 | 1,071.1 | 1,178.7 | 1,007.7 | 1,099.8 | 1,079.4 | ||
Funding and liquidity | ||||||||||
Group liquidity pool (£bn) | 290 | 266 | 327 | 298 | 237 | 211 | 226 | 238 | ||
Liquidity coverage ratio | 161% | 162% | 181% | 186% | 155% | 160% | 151% | 156% | ||
Loan: deposit ratio | 69% | 71% | 70% | 76% | 79% | 82% | 82% | 82% |
1 | Refer to pages 21 to 26 for further information on how capital, RWAs and leverage are calculated. |
Quarterly Results by Business
Barclays UK | ||||||||||
Q121 | Q420 | Q320 | Q220 | Q120 | Q419 | Q319 | Q219 | |||
Income statement information | £m | £m | £m | £m | £m | £m | £m | £m | ||
Net interest income | 1,281 | 1,317 | 1,280 | 1,225 | 1,412 | 1,478 | 1,503 | 1,438 | ||
Net fee, commission and other income | 295 | 309 | 270 | 242 | 292 | 481 | 343 | 333 | ||
Total income | 1,576 | 1,626 | 1,550 | 1,467 | 1,704 | 1,959 | 1,846 | 1,771 | ||
Credit impairment charges | (77) | (170) | (233) | (583) | (481) | (190) | (101) | (230) | ||
Net operating income | 1,499 | 1,456 | 1,317 | 884 | 1,223 | 1,769 | 1,745 | 1,541 | ||
Operating costs | (1,036) | (1,134) | (1,095) | (1,018) | (1,023) | (1,023) | (952) | (1,022) | ||
UK bank levy | - | (50) | - | - | - | (41) | - | - | ||
Litigation and conduct | (3) | 4 | (25) | (6) | (5) | (58) | (1,480) | (41) | ||
Total operating expenses | (1,039) | (1,180) | (1,120) | (1,024) | (1,028) | (1,122) | (2,432) | (1,063) | ||
Other net income/(expenses) | - | 6 | (1) | 13 | - | - | - | (1) | ||
Profit/(loss) before tax | 460 | 282 | 196 | (127) | 195 | 647 | (687) | 477 | ||
Attributable profit/(loss) | 298 | 160 | 113 | (123) | 175 | 438 | (907) | 328 | ||
Balance sheet information | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | ||
Loans and advances to customers at amortised cost | 205.7 | 205.4 | 203.9 | 202.0 | 195.7 | 193.7 | 193.2 | 189.1 | ||
Total assets | 309.1 | 289.1 | 294.5 | 287.6 | 267.5 | 257.8 | 257.9 | 259.0 | ||
Customer deposits at amortised cost | 247.5 | 240.5 | 232.0 | 225.7 | 207.5 | 205.5 | 203.3 | 200.9 | ||
Loan: deposit ratio | 88% | 89% | 91% | 92% | 96% | 96% | 97% | 97% | ||
Risk weighted assets | 72.7 | 73.7 | 76.2 | 77.9 | 77.7 | 74.9 | 76.8 | 76.2 | ||
Period end allocated tangible equity | 10.0 | 9.7 | 10.0 | 10.3 | 10.3 | 10.3 | 10.4 | 10.3 | ||
Performance measures | ||||||||||
Return on average allocated tangible equity | 12.0% | 6.5% | 4.5% | (4.8%) | 6.9% | 17.0% | (34.9%) | 12.7% | ||
Average allocated tangible equity (£bn) | 9.9 | 9.8 | 10.1 | 10.3 | 10.1 | 10.3 | 10.4 | 10.3 | ||
Cost: income ratio | 66% | 73% | 72% | 70% | 60% | 57% | 132% | 60% | ||
Loan loss rate (bps) | 14 | 31 | 43 | 111 | 96 | 38 | 20 | 47 | ||
Net interest margin | 2.54% | 2.56% | 2.51% | 2.48% | 2.91% | 3.03% | 3.10% | 3.05% |
Analysis of Barclays UK | Q121 | Q420 | Q320 | Q220 | Q120 | Q419 | Q319 | Q219 | ||
Analysis of total income | £m | £m | £m | £m | £m | £m | £m | £m | ||
Personal Banking | 923 | 895 | 833 | 826 | 968 | 1,064 | 1,035 | 946 | ||
Barclaycard Consumer UK | 315 | 354 | 362 | 367 | 436 | 533 | 472 | 497 | ||
Business Banking | 338 | 377 | 355 | 274 | 300 | 362 | 339 | 328 | ||
Total income | 1,576 | 1,626 | 1,550 | 1,467 | 1,704 | 1,959 | 1,846 | 1,771 | ||
Analysis of credit impairment charges | ||||||||||
Personal Banking | (22) | (68) | (48) | (130) | (134) | (71) | (36) | (36) | ||
Barclaycard Consumer UK | (36) | (78) | (106) | (396) | (301) | (108) | (49) | (175) | ||
Business Banking | (19) | (24) | (79) | (57) | (46) | (11) | (16) | (19) | ||
Total credit impairment charges | (77) | (170) | (233) | (583) | (481) | (190) | (101) | (230) | ||
Analysis of loans and advances to customers at amortised cost | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | ||
Personal Banking | 160.4 | 157.3 | 155.7 | 154.9 | 153.4 | 151.9 | 150.1 | 147.3 | ||
Barclaycard Consumer UK | 8.7 | 9.9 | 10.7 | 11.5 | 13.6 | 14.7 | 14.9 | 15.1 | ||
Business Banking | 36.6 | 38.2 | 37.5 | 35.6 | 28.7 | 27.1 | 28.2 | 26.7 | ||
Total loans and advances to customers at amortised cost | 205.7 | 205.4 | 203.9 | 202.0 | 195.7 | 193.7 | 193.2 | 189.1 | ||
Analysis of customer deposits at amortised cost | ||||||||||
Personal Banking | 186.0 | 179.7 | 173.2 | 169.6 | 161.4 | 159.2 | 157.9 | 156.3 | ||
Barclaycard Consumer UK | 0.1 | 0.1 | 0.1 | 0.1 | - | - | - | - | ||
Business Banking | 61.4 | 60.7 | 58.7 | 56.0 | 46.1 | 46.3 | 45.4 | 44.6 | ||
Total customer deposits at amortised cost | 247.5 | 240.5 | 232.0 | 225.7 | 207.5 | 205.5 | 203.3 | 200.9 |
Barclays International | ||||||||||
Q121 | Q420 | Q320 | Q220 | Q120 | Q419 | Q319 | Q219 | |||
Income statement information | £m | £m | £m | £m | £m | £m | £m | £m | ||
Net interest income | 748 | 614 | 823 | 847 | 998 | 965 | 1,059 | 1,017 | ||
Net trading income | 1,934 | 1,372 | 1,528 | 1,660 | 2,360 | 929 | 1,110 | 1,016 | ||
Net fee, commission and other income | 1,717 | 1,500 | 1,430 | 1,503 | 1,286 | 1,558 | 1,581 | 1,870 | ||
Total income | 4,399 | 3,486 | 3,781 | 4,010 | 4,644 | 3,452 | 3,750 | 3,903 | ||
Credit impairment releases/(charges) | 22 | (291) | (370) | (1,010) | (1,609) | (329) | (352) | (247) | ||
Net operating income | 4,421 | 3,195 | 3,411 | 3,000 | 3,035 | 3,123 | 3,398 | 3,656 | ||
Operating costs | (2,438) | (2,133) | (2,227) | (2,186) | (2,219) | (2,240) | (2,282) | (2,435) | ||
UK bank levy | - | (240) | - | - | - | (174) | - | - | ||
Litigation and conduct | (21) | (9) | (28) | (11) | - | (86) | - | (11) | ||
Total operating expenses | (2,459) | (2,382) | (2,255) | (2,197) | (2,219) | (2,500) | (2,282) | (2,446) | ||
Other net income | 9 | 9 | 9 | 4 | 6 | 17 | 21 | 13 | ||
Profit before tax | 1,971 | 822 | 1,165 | 807 | 822 | 640 | 1,137 | 1,223 | ||
Attributable profit | 1,431 | 441 | 782 | 468 | 529 | 397 | 799 | 832 | ||
Balance sheet information | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | ||
Loans and advances at amortised cost | 123.5 | 122.7 | 128.0 | 138.1 | 167.0 | 132.8 | 138.1 | 134.8 | ||
Trading portfolio assets | 131.1 | 127.7 | 122.3 | 109.5 | 101.6 | 113.3 | 119.4 | 120.0 | ||
Derivative financial instrument assets | 269.4 | 301.8 | 295.9 | 306.8 | 341.5 | 228.9 | 286.0 | 243.8 | ||
Financial assets at fair value through the income statement | 197.5 | 170.7 | 178.2 | 154.3 | 188.4 | 128.4 | 158.0 | 154.7 | ||
Cash collateral and settlement balances | 109.7 | 97.5 | 121.8 | 130.8 | 153.2 | 79.4 | 112.5 | 101.3 | ||
Other assets | 221.7 | 221.4 | 261.7 | 236.3 | 201.5 | 178.6 | 195.6 | 196.8 | ||
Total assets | 1,052.9 | 1,041.8 | 1,107.9 | 1,075.8 | 1,153.2 | 861.4 | 1,009.6 | 951.4 | ||
Deposits at amortised cost | 251.2 | 240.5 | 262.4 | 241.2 | 263.3 | 210.0 | 217.6 | 212.0 | ||
Derivative financial instrument liabilities | 260.2 | 300.4 | 293.3 | 307.6 | 338.8 | 228.9 | 283.3 | 243.0 | ||
Loan: deposit ratio | 49% | 51% | 49% | 57% | 63% | 63% | 63% | 64% | ||
Risk weighted assets | 230.0 | 222.3 | 224.7 | 231.2 | 237.9 | 209.2 | 223.1 | 214.8 | ||
Period end allocated tangible equity | 32.7 | 30.2 | 30.5 | 31.6 | 33.1 | 29.6 | 31.4 | 30.2 | ||
Performance measures | ||||||||||
Return on average allocated tangible equity | 17.7% | 5.8% | 10.2% | 5.6% | 6.8% | 5.1% | 9.9% | 10.7% | ||
Average allocated tangible equity (£bn) | 32.3 | 30.5 | 30.6 | 33.5 | 31.2 | 30.9 | 32.2 | 31.1 | ||
Cost: income ratio | 56% | 68% | 60% | 55% | 48% | 72% | 61% | 63% | ||
Loan loss rate (bps) | (7) | 90 | 112 | 284 | 377 | 96 | 99 | 72 | ||
Net interest margin | 3.92% | 3.41% | 3.79% | 3.43% | 3.93% | 4.29% | 4.10% | 3.91% |
Analysis of Barclays International | ||||||||||
Corporate and Investment Bank | Q121 | Q420 | Q320 | Q220 | Q120 | Q419 | Q319 | Q219 | ||
Income statement information | £m | £m | £m | £m | £m | £m | £m | £m | ||
FICC | 1,204 | 812 | 1,000 | 1,468 | 1,858 | 726 | 816 | 920 | ||
Equities | 932 | 542 | 691 | 674 | 564 | 409 | 494 | 517 | ||
Markets | 2,136 | 1,354 | 1,691 | 2,142 | 2,422 | 1,135 | 1,310 | 1,437 | ||
Advisory | 163 | 232 | 90 | 84 | 155 | 202 | 221 | 221 | ||
Equity capital markets | 243 | 104 | 122 | 185 | 62 | 56 | 86 | 104 | ||
Debt capital markets | 453 | 418 | 398 | 463 | 418 | 322 | 381 | 373 | ||
Banking fees | 859 | 754 | 610 | 732 | 635 | 580 | 688 | 698 | ||
Corporate lending | 206 | 186 | 232 | 61 | 111 | 202 | 195 | 216 | ||
Transaction banking | 393 | 344 | 372 | 381 | 449 | 397 | 424 | 444 | ||
Corporate | 599 | 530 | 604 | 442 | 560 | 599 | 619 | 660 | ||
Total income1 | 3,594 | 2,638 | 2,905 | 3,316 | 3,617 | 2,314 | 2,617 | 2,795 | ||
Credit impairment releases/(charges) | 43 | (52) | (187) | (596) | (724) | (30) | (31) | (44) | ||
Net operating income | 3,637 | 2,586 | 2,718 | 2,720 | 2,893 | 2,284 | 2,586 | 2,751 | ||
Operating costs | (1,886) | (1,603) | (1,716) | (1,680) | (1,690) | (1,691) | (1,712) | (1,860) | ||
UK bank levy | - | (226) | - | - | - | (156) | - | - | ||
Litigation and conduct | (1) | 2 | (3) | (3) | - | (79) | (4) | (7) | ||
Total operating expenses | (1,887) | (1,827) | (1,719) | (1,683) | (1,690) | (1,926) | (1,716) | (1,867) | ||
Other net income | 1 | 2 | 1 | 3 | - | 1 | 12 | 3 | ||
Profit before tax | 1,751 | 761 | 1,000 | 1,040 | 1,203 | 359 | 882 | 887 | ||
Attributable profit | 1,263 | 413 | 627 | 694 | 820 | 193 | 609 | 596 | ||
Balance sheet information | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | ||
Loans and advances at amortised cost | 94.3 | 92.4 | 96.8 | 104.9 | 128.2 | 92.0 | 95.8 | 92.1 | ||
Trading portfolio assets | 130.9 | 127.5 | 122.2 | 109.3 | 101.5 | 113.3 | 119.3 | 119.9 | ||
Derivative financial instruments assets | 269.4 | 301.7 | 295.9 | 306.7 | 341.4 | 228.8 | 286.0 | 243.7 | ||
Financial assets at fair value through the income statement | 197.3 | 170.4 | 177.9 | 153.7 | 187.8 | 127.7 | 157.3 | 154.1 | ||
Cash collateral and settlement balances | 108.8 | 96.7 | 121.0 | 129.7 | 152.2 | 78.5 | 111.6 | 100.4 | ||
Other assets | 190.8 | 194.9 | 228.9 | 205.5 | 171.4 | 155.3 | 171.5 | 168.1 | ||
Total assets | 991.5 | 983.6 | 1,042.7 | 1,009.8 | 1,082.5 | 795.6 | 941.5 | 878.3 | ||
Deposits at amortised cost | 185.2 | 175.2 | 195.6 | 173.9 | 198.4 | 146.2 | 152.1 | 145.4 | ||
Derivative financial instrument liabilities | 260.2 | 300.3 | 293.2 | 307.6 | 338.7 | 228.9 | 283.2 | 242.9 | ||
Risk weighted assets | 201.3 | 192.2 | 193.3 | 198.3 | 201.7 | 171.5 | 184.9 | 175.9 | ||
Performance measures | ||||||||||
Return on average allocated tangible equity | 17.9% | 6.3% | 9.5% | 9.6% | 12.5% | 3.0% | 9.1% | 9.2% | ||
Average allocated tangible equity (£bn) | 28.2 | 26.3 | 26.4 | 29.0 | 26.2 | 25.8 | 26.9 | 25.8 | ||
Cost: income ratio | 53% | 69% | 59% | 51% | 47% | 83% | 66% | 67% | ||
1 | From Q121, a change in the allocation of the net impact of treasury operations to businesses has been made to reflect changes in the business balance sheets. |
Analysis of Barclays International | ||||||||||
Consumer, Cards and Payments | Q121 | Q420 | Q320 | Q220 | Q120 | Q419 | Q319 | Q219 | ||
Income statement information | £m | £m | £m | £m | £m | £m | £m | £m | ||
Net interest income | 478 | 504 | 518 | 513 | 663 | 717 | 720 | 720 | ||
Net fee, commission, trading and other income | 327 | 344 | 358 | 181 | 364 | 421 | 413 | 388 | ||
Total income | 805 | 848 | 876 | 694 | 1,027 | 1,138 | 1,133 | 1,108 | ||
Credit impairment charges | (21) | (239) | (183) | (414) | (885) | (299) | (321) | (203) | ||
Net operating income | 784 | 609 | 693 | 280 | 142 | 839 | 812 | 905 | ||
Operating costs | (552) | (530) | (511) | (506) | (529) | (549) | (570) | (575) | ||
UK bank levy | - | (14) | - | - | - | (18) | - | - | ||
Litigation and conduct | (20) | (11) | (25) | (8) | - | (7) | 4 | (4) | ||
Total operating expenses | (572) | (555) | (536) | (514) | (529) | (574) | (566) | (579) | ||
Other net income | 8 | 7 | 8 | 1 | 6 | 16 | 9 | 10 | ||
Profit/(loss) before tax | 220 | 61 | 165 | (233) | (381) | 281 | 255 | 336 | ||
Attributable profit/(loss) | 168 | 28 | 155 | (226) | (291) | 204 | 190 | 236 | ||
Balance sheet information | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | ||
Loans and advances at amortised cost | 29.2 | 30.3 | 31.2 | 33.2 | 38.8 | 40.8 | 42.3 | 42.7 | ||
Total assets | 61.4 | 58.2 | 65.2 | 66.0 | 70.7 | 65.8 | 68.1 | 73.1 | ||
Deposits at amortised cost | 66.0 | 65.3 | 66.8 | 67.3 | 64.9 | 63.8 | 65.5 | 66.6 | ||
Risk weighted assets | 28.8 | 30.1 | 31.4 | 32.9 | 36.2 | 37.7 | 38.2 | 38.9 | ||
Performance measures | ||||||||||
Return on average allocated tangible equity | 16.5% | 2.7% | 14.7% | (20.2%) | (23.5%) | 15.9% | 14.2% | 17.8% | ||
Average allocated tangible equity (£bn) | 4.1 | 4.2 | 4.2 | 4.5 | 5.0 | 5.1 | 5.3 | 5.3 | ||
Cost: income ratio | 71% | 65% | 61% | 74% | 52% | 50% | 50% | 52% | ||
Loan loss rate (bps) | 27 | 286 | 211 | 455 | 846 | 273 | 283 | 180 | ||
Head Office | ||||||||||
Q121 | Q420 | Q320 | Q220 | Q120 | Q419 | Q319 | Q219 | |||
Income statement information | £m | £m | £m | £m | £m | £m | £m | £m | ||
Net interest income | (178) | (86) | (48) | (180) | (79) | (99) | (117) | (95) | ||
Net fee, commission and other income | 103 | (85) | (79) | 41 | 14 | (11) | 62 | (41) | ||
Total income | (75) | (171) | (127) | (139) | (65) | (110) | (55) | (136) | ||
Credit impairment charges | - | (31) | (5) | (30) | (25) | (4) | (8) | (3) | ||
Net operating expenses | (75) | (202) | (132) | (169) | (90) | (114) | (63) | (139) | ||
Operating costs | (71) | (213) | (69) | (106) | (11) | (45) | (59) | (44) | ||
UK bank levy | - | (9) | - | - | - | (11) | - | - | ||
Litigation and conduct | (9) | (42) | (23) | (3) | (5) | (23) | (88) | (1) | ||
Total operating expenses | (80) | (264) | (92) | (109) | (16) | (79) | (147) | (45) | ||
Other net income/(expenses) | 123 | 8 | 10 | (43) | 2 | 3 | 6 | 15 | ||
Loss before tax | (32) | (458) | (214) | (321) | (104) | (190) | (204) | (169) | ||
Attributable loss | (25) | (381) | (284) | (255) | (99) | (154) | (184) | (126) | ||
Balance sheet information | £bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | ||
Total assets | 17.7 | 18.6 | 19.3 | 21.7 | 23.6 | 21.0 | 22.9 | 22.4 | ||
Risk weighted assets | 10.7 | 10.2 | 9.8 | 9.9 | 10.0 | 11.0 | 13.4 | 28.1 | ||
Period end allocated tangible equity | 3.3 | 6.8 | 7.1 | 7.4 | 6.0 | 5.6 | 5.5 | 7.0 | ||
Performance measures | ||||||||||
Average allocated tangible equity (£bn) | 4.3 | 7.3 | 7.6 | 6.4 | 5.6 | 5.2 | 5.8 | 4.8 |
Performance Management
Margins and balances | ||||||
Three months ended 31.03.21 | Three months ended 31.03.20 | |||||
Net interest income | Average customer assets | Net interest margin | Net interest income | Average customer assets | Net interest margin | |
£m | £m | % | £m | £m | % | |
Barclays UK | 1,281 | 204,663 | 2.54 | 1,412 | 195,204 | 2.91 |
Barclays International1,2 | 755 | 78,230 | 3.92 | 980 | 100,171 | 3.93 |
Total Barclays UK and Barclays International | 2,036 | 282,893 | 2.92 | 2,392 | 295,375 | 3.26 |
Other3 | (185) | (61) | ||||
Total Barclays Group | 1,851 | 2,331 | ||||
1 | Barclays International margins include IEL balances within the investment banking business. |
2 | Barclays amended the presentation of the premium paid for purchased financial guarantees which are embedded in notes it issues directly to the market in Q420 from net investment income to interest expense within net interest income. Had the equivalent Q120 interest expense been recognised in net interest income, the Barclays International and Total Barclays UK and Barclays International NIMs would have been 3.84% and 3.22% respectively. |
3 | Other includes Head Office and non-lending related investment banking businesses not included in Barclays International margins. |
The Group's combined product and equity structural hedge notional as at 31 March 2021 was £192bn, with an average duration of 2.5 to 3 years. Group net interest income includes gross structural hedge contributions of £0.3bn (Q120: £0.4bn) and net structural hedge contributions of £0.3bn (Q120: £0.2bn). Gross structural hedge contributions represent the absolute level of interest earned from the fixed receipts on the basket of swaps in the structural hedge, while the net structural hedge contributions represent the net interest earned on the difference between the structural hedge rate and prevailing floating rates.
Quarterly analysis for Barclays UK and Barclays International | Net interest income | Average customer assets | Net interest margin |
Three months ended 31.12.20 | £m | £m | % |
Barclays UK | 1,317 | 204,315 | 2.56 |
Barclays International1,2 | 696 | 81,312 | 3.41 |
Total Barclays UK and Barclays International | 2,013 | 285,627 | 2.80 |
Three months ended 30.09.20 | |||
Barclays UK | 1,280 | 203,089 | 2.51 |
Barclays International1,2 | 838 | 88,032 | 3.79 |
Total Barclays UK and Barclays International | 2,118 | 291,121 | 2.89 |
Three months ended 30.06.20 | |||
Barclays UK | 1,225 | 199,039 | 2.48 |
Barclays International1,2 | 868 | 101,706 | 3.43 |
Total Barclays UK and Barclays International | 2,093 | 300,745 | 2.80 |
1 | Barclays International margins include IEL balances within the investment banking business. |
2 | The reclassification of expense of the premium paid for purchased financial guarantees from net investment income to net interest income was recognised in full in Q420 and resulted in a 0.48% reduction on the Q420 Barclays International NIM and 0.14% reduction on the Q420 Total Barclays UK and Barclays International NIM. Had the equivalent impact been reflected in the respective quarters, the Barclays International NIM would have been 3.33% in Q220, 3.68% in Q320 and 3.77% in Q420. Total Barclays UK and Barclays International NIMs would have been 2.77% in Q220, 2.86% in Q320 and 2.91% in Q420 respectively. |
Credit Risk
Loans and advances at amortised cost by stage
The table below presents an analysis of loans and advances at amortised cost by gross exposure, impairment allowance, impairment charge and coverage ratio by stage allocation and business segment as at 31 March 2021. Also included are off-balance sheet loan commitments and financial guarantee contracts by gross exposure, impairment allowance and coverage ratio by stage allocation as at 31 March 2021.
Impairment allowance under IFRS 9 considers both the drawn and the undrawn counterparty exposure. For retail portfolios, the total impairment allowance is allocated to the drawn exposure to the extent that the allowance does not exceed the exposure, as expected credit loss (ECL) is not reported separately. Any excess is reported on the liability side of the balance sheet as a provision. For wholesale portfolios, the impairment allowance on the undrawn exposure is reported on the liability side of the balance sheet as a provision.
Gross exposure | Impairment allowance | Net exposure | ||||||||
Stage 1 | Stage 2 | Stage 3 | Total | Stage 1 | Stage 2 | Stage 3 | Total | |||
As at 31.03.21 | £m | £m | £m | £m | £m | £m | £m | £m | £m | |
Barclays UK | 155,477 | 24,114 | 2,833 | 182,424 | 308 | 1,422 | 1,089 | 2,819 | 179,605 | |
Barclays International | 19,955 | 5,219 | 1,858 | 27,032 | 364 | 1,198 | 1,101 | 2,663 | 24,369 | |
Head Office | 4,011 | 565 | 778 | 5,354 | 4 | 45 | 358 | 407 | 4,947 | |
Total Barclays Group retail | 179,443 | 29,898 | 5,469 | 214,810 | 676 | 2,665 | 2,548 | 5,889 | 208,921 | |
Barclays UK | 32,208 | 4,092 | 1,088 | 37,388 | 11 | 135 | 102 | 248 | 37,140 | |
Barclays International | 84,199 | 14,855 | 1,779 | 100,833 | 316 | 508 | 835 | 1,659 | 99,174 | |
Head Office | 542 | - | 32 | 574 | - | - | 31 | 31 | 543 | |
Total Barclays Group wholesale1 | 116,949 | 18,947 | 2,899 | 138,795 | 327 | 643 | 968 | 1,938 | 136,857 | |
Total loans and advances at amortised cost | 296,392 | 48,845 | 8,368 | 353,605 | 1,003 | 3,308 | 3,516 | 7,827 | 345,778 | |
Off-balance sheet loan commitments and financial guarantee contracts2 | 298,695 | 50,618 | 787 | 350,100 | 228 | 731 | 43 | 1,002 | 349,098 | |
Total3 | 595,087 | 99,463 | 9,155 | 703,705 | 1,231 | 4,039 | 3,559 | 8,829 | 694,876 | |
As at 31.03.21 | Three months ended 31.03.21 | |||||||||
Coverage ratio | Loan impairment charge and loan loss rate4 | |||||||||
Stage 1 | Stage 2 | Stage 3 | Total | Loan impairment charge | Loan loss rate | |||||
% | % | % | % | £m | bps | |||||
Barclays UK | 0.2 | 5.9 | 38.4 | 1.5 | 28 | 6 | ||||
Barclays International | 1.8 | 23.0 | 59.3 | 9.9 | 20 | 30 | ||||
Head Office | 0.1 | 8.0 | 46.0 | 7.6 | (1) | - | ||||
Total Barclays Group retail | 0.4 | 8.9 | 46.6 | 2.7 | 47 | 9 | ||||
Barclays UK | - | 3.3 | 9.4 | 0.7 | 14 | 15 | ||||
Barclays International | 0.4 | 3.4 | 46.9 | 1.6 | 55 | 22 | ||||
Head Office | - | - | 96.9 | 5.4 | 1 | 71 | ||||
Total Barclays Group wholesale1 | 0.3 | 3.4 | 33.4 | 1.4 | 70 | 20 | ||||
Total loans and advances at amortised cost | 0.3 | 6.8 | 42.0 | 2.2 | 117 | 13 | ||||
Off-balance sheet loan commitments and financial guarantee contracts2 | 0.1 | 1.4 | 5.5 | 0.3 | (57) | |||||
Other financial assets subject to impairment3 | (5) | |||||||||
Total4 | 0.2 | 4.1 | 38.9 | 1.3 | 55 | |||||
1 | Includes Wealth and Private Banking exposures measured on an individual customer exposure basis, and excludes Business Banking exposures that are managed on a collective basis. The net impact is a difference in total exposure of £8,133m of balances reported as wholesale loans on page 18 in the Loans and advances at amortised cost by product disclosure. |
2 | Excludes loan commitments and financial guarantees of £18.9bn carried at fair value. |
3 | Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £188.1bn and impairment allowance of £130m. This comprises £19m ECL on £186.3bn stage 1 assets, £3m on £1.7bn stage 2 fair value through other comprehensive income assets, other assets, cash collateral and settlement balances and £108m on £113m stage 3 other assets. |
4 | Q121 loan impairment charge represents three months of impairment charge, annualised to calculate the loan loss rate. The loan loss rate is 6bps after applying the total impairment charge of £55m. |
Gross exposure | Impairment allowance | Net exposure | ||||||||
Stage 1 | Stage 2 | Stage 3 | Total | Stage 1 | Stage 2 | Stage 3 | Total | |||
As at 31.12.20 | £m | £m | £m | £m | £m | £m | £m | £m | £m | |
Barclays UK | 153,250 | 23,896 | 2,732 | 179,878 | 332 | 1,509 | 1,147 | 2,988 | 176,890 | |
Barclays International1 | 21,048 | 5,500 | 1,992 | 28,540 | 396 | 1,329 | 1,205 | 2,930 | 25,610 | |
Head Office | 4,267 | 720 | 844 | 5,831 | 4 | 51 | 380 | 435 | 5,396 | |
Total Barclays Group retail | 178,565 | 30,116 | 5,568 | 214,249 | 732 | 2,889 | 2,732 | 6,353 | 207,896 | |
Barclays UK | 31,918 | 4,325 | 1,126 | 37,369 | 13 | 129 | 116 | 258 | 37,111 | |
Barclays International1 | 79,911 | 16,565 | 2,270 | 98,746 | 288 | 546 | 859 | 1,693 | 97,053 | |
Head Office | 570 | - | 33 | 603 | - | - | 31 | 31 | 572 | |
Total Barclays Group wholesale2 | 112,399 | 20,890 | 3,429 | 136,718 | 301 | 675 | 1,006 | 1,982 | 134,736 | |
Total loans and advances at amortised cost | 290,964 | 51,006 | 8,997 | 350,967 | 1,033 | 3,564 | 3,738 | 8,335 | 342,632 | |
Off-balance sheet loan commitments and financial guarantee contracts3 | 289,939 | 52,891 | 2,330 | 345,160 | 256 | 758 | 50 | 1,064 | 344,096 | |
Total4 | 580,903 | 103,897 | 11,327 | 696,127 | 1,289 | 4,322 | 3,788 | 9,399 | 686,728 | |
As at 31.12.20 | Year ended 31.12.20 | |||||||||
Coverage ratio | Loan impairment charge and loan loss rate4 | |||||||||
Stage 1 | Stage 2 | Stage 3 | Total | Loan impairment charge | Loan loss rate | |||||
% | % | % | % | £m | bps | |||||
Barclays UK | 0.2 | 6.3 | 42.0 | 1.7 | 1,070 | 59 | ||||
Barclays International1 | 1.9 | 24.2 | 60.5 | 10.3 | 1,680 | 589 | ||||
Head Office | 0.1 | 7.1 | 45.0 | 7.5 | 91 | 156 | ||||
Total Barclays Group retail | 0.4 | 9.6 | 49.1 | 3.0 | 2,841 | 133 | ||||
Barclays UK | - | 3.0 | 10.3 | 0.7 | 154 | 41 | ||||
Barclays International1 | 0.4 | 3.3 | 37.8 | 1.7 | 914 | 93 | ||||
Head Office | - | - | 93.9 | 5.1 | - | - | ||||
Total Barclays Group wholesale2 | 0.3 | 3.2 | 29.3 | 1.4 | 1,068 | 78 | ||||
Total loans and advances at amortised cost | 0.4 | 7.0 | 41.5 | 2.4 | 3,909 | 111 | ||||
Off-balance sheet loan commitments and financial guarantee contracts3 | 0.1 | 1.4 | 2.1 | 0.3 | 776 | |||||
Other financial assets subject to impairment4 | 153 | |||||||||
Total5 | 0.2 | 4.2 | 33.4 | 1.4 | 4,838 | |||||
1 | Private Banking have refined the methodology to classify £5bn of their exposure between Wholesale and Retail during the year. |
2 | Includes Wealth and Private Banking exposures measured on an individual customer exposure basis, and excludes Business Banking exposures that are managed on a collective basis. The net impact is a difference in total exposure of £7,551m of balances reported as wholesale loans on page 18 in the Loans and advances at amortised cost by product disclosure. |
3 | Excludes loan commitments and financial guarantees of £9.5bn carried at fair value. |
4 | Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £180.3bn and impairment allowance of £165m. This comprises £11m ECL on £175.7bn stage 1 assets, £9m on £4.4bn stage 2 fair value through other comprehensive income assets, other assets, cash collateral and settlement balances and £145m on £154m stage 3 other assets. |
5 | The loan loss rate is 138bps after applying the total impairment charge of £4,838m. |
Loans and advances at amortised cost by product
The table below presents a breakdown of loans and advances at amortised cost and the impairment allowance with stage allocation by asset classification.
Stage 2 | |||||||
As at 31.03.21 | Stage 1 | Not past due | >30 days past due | Total | Stage 3 | Total | |
Gross exposure | £m | £m | £m | £m | £m | £m | £m |
Home loans | 141,273 | 16,919 | 1,960 | 1,059 | 19,938 | 2,229 | 163,440 |
Credit cards, unsecured loans and other retail lending | 30,797 | 8,785 | 344 | 289 | 9,418 | 3,022 | 43,237 |
Wholesale loans | 124,322 | 18,959 | 329 | 201 | 19,489 | 3,117 | 146,928 |
Total | 296,392 | 44,663 | 2,633 | 1,549 | 48,845 | 8,368 | 353,605 |
Impairment allowance | |||||||
Home loans | 34 | 55 | 13 | 11 | 79 | 397 | 510 |
Credit cards, unsecured loans and other retail lending | 624 | 2,228 | 144 | 177 | 2,549 | 2,091 | 5,264 |
Wholesale loans | 345 | 672 | 5 | 3 | 680 | 1,028 | 2,053 |
Total | 1,003 | 2,955 | 162 | 191 | 3,308 | 3,516 | 7,827 |
Net exposure | |||||||
Home loans | 141,239 | 16,864 | 1,947 | 1,048 | 19,859 | 1,832 | 162,930 |
Credit cards, unsecured loans and other retail lending | 30,173 | 6,557 | 200 | 112 | 6,869 | 931 | 37,973 |
Wholesale loans | 123,977 | 18,287 | 324 | 198 | 18,809 | 2,089 | 144,875 |
Total | 295,389 | 41,708 | 2,471 | 1,358 | 45,537 | 4,852 | 345,778 |
Coverage ratio | % | % | % | % | % | % | % |
Home loans | - | 0.3 | 0.7 | 1.0 | 0.4 | 17.8 | 0.3 |
Credit cards, unsecured loans and other retail lending | 2.0 | 25.4 | 41.9 | 61.2 | 27.1 | 69.2 | 12.2 |
Wholesale loans | 0.3 | 3.5 | 1.5 | 1.5 | 3.5 | 33.0 | 1.4 |
Total | 0.3 | 6.6 | 6.2 | 12.3 | 6.8 | 42.0 | 2.2 |
As at 31.12.20 | |||||||
Gross exposure | £m | £m | £m | £m | £m | £m | £m |
Home loans | 138,639 | 16,651 | 1,785 | 876 | 19,312 | 2,234 | 160,185 |
Credit cards, unsecured loans and other retail lending | 33,021 | 9,470 | 544 | 306 | 10,320 | 3,172 | 46,513 |
Wholesale loans | 119,304 | 19,501 | 1,097 | 776 | 21,374 | 3,591 | 144,269 |
Total | 290,964 | 45,622 | 3,426 | 1,958 | 51,006 | 8,997 | 350,967 |
Impairment allowance | |||||||
Home loans | 33 | 57 | 13 | 14 | 84 | 421 | 538 |
Credit cards, unsecured loans and other retail lending | 680 | 2,382 | 180 | 207 | 2,769 | 2,251 | 5,700 |
Wholesale loans | 320 | 650 | 50 | 11 | 711 | 1,066 | 2,097 |
Total | 1,033 | 3,089 | 243 | 232 | 3,564 | 3,738 | 8,335 |
Net exposure | |||||||
Home loans | 138,606 | 16,594 | 1,772 | 862 | 19,228 | 1,813 | 159,647 |
Credit cards, unsecured loans and other retail lending | 32,341 | 7,088 | 364 | 99 | 7,551 | 921 | 40,813 |
Wholesale loans | 118,984 | 18,851 | 1,047 | 765 | 20,663 | 2,525 | 142,172 |
Total | 289,931 | 42,533 | 3,183 | 1,726 | 47,442 | 5,259 | 342,632 |
Coverage ratio | % | % | % | % | % | % | % |
Home loans | - | 0.3 | 0.7 | 1.6 | 0.4 | 18.8 | 0.3 |
Credit cards, unsecured loans and other retail lending | 2.1 | 25.2 | 33.1 | 67.6 | 26.8 | 71.0 | 12.3 |
Wholesale loans | 0.3 | 3.3 | 4.6 | 1.4 | 3.3 | 29.7 | 1.5 |
Total | 0.4 | 6.8 | 7.1 | 11.8 | 7.0 | 41.5 | 2.4 |
Measurement uncertainty
During the latter part of Q121, macroeconomic indicators became more positive than at Q420, particularly in the UK with improved economic growth and lower unemployment consensus forecasts in response to the UK Budget announcement on 3 March 2021 and the progress of the COVID-19 vaccine roll out programme. In the US, new government stimulus was announced in March 2021, including a $1.9trn Rescue Plan, and a COVID-19 vaccine programme well underway. However, global economic uncertainty remains high as the COVID-19 pandemic continues to evolve and practical challenges remain in inoculation programmes.
In response to the changing economic environment, key baseline macroeconomic indicators were refreshed at Q121. However, because the macroeconomic outlook remains uncertain and has only recently shown improvement, the impact from these consensus updates has not been reflected in the Q121 ECL provision level. This has been based on the more conservative macroeconomic indicators of the Q420 ECL scenarios, rolled forward by one quarter, and updated to reflect changes in balances and individually assessed impaired names during the quarter. If these favourable macroeconomic indicators persist, an adjustment will be made to the provision level.
Sensitivity analysis has been completed to estimate the impact of applying the refreshed Q121 baseline to material portfolios. This high-level analysis indicated that, all other things being equal, this change in key macroeconomic variables would result in a reduction to the modelled ECL stock of c£0.5bn from the material portfolios, should positive macroeconomic indicators persist. The macroeconomic variables used in the sensitivity analysis are disclosed on the following page.
Management adjustments to models for impairment
The real economic impact of the COVID-19 pandemic may only become clear once support measures put in place by governments begin to fall away. Government support schemes are currently scheduled to run until cQ321 in the major jurisdictions in which Barclays operates. In addition to the above ECL model sensitivity for which no adjustment has been made, management adjustments to models for impairment were retained and amounted to £1,223m (Q420: £1,388m). These included economic uncertainty adjustments recognised at year end 2020 which addressed the temporary nature of ongoing government support, the uncertainty in relation to the timing of stress and the range of economic uncertainty.
The tables below show the primary consensus macroeconomic variables in the Q121 Baseline scenario and the probability weights applied to each rolled forward scenario.
Baseline average macroeconomic variables used in the calculation of ECL | |||
The calculation of ECL was based on the Q420 macroeconomic variables rolled forward by one quarter. | |||
2021 | 2022 | 2023 | |
As at 31.03.21 | % | % | % |
UK GDP1 | 3.3 | 3.4 | 2.9 |
UK unemployment2 | 6.0 | 6.6 | 6.0 |
UK HPI3 | 2.4 | 2.3 | 4.2 |
UK bank rate | 0.1 | (0.1) | - |
US GDP1 | 1.9 | 3.2 | 2.9 |
US unemployment4 | 7.3 | 5.8 | 5.6 |
US HPI5 | 2.4 | 4.2 | 4.7 |
US federal funds rate | 0.3 | 0.3 | 0.3 |
2021 | 2022 | 2023 | |
As at 31.12.20 | % | % | % |
UK GDP1 | 6.3 | 3.3 | 2.6 |
UK unemployment2 | 6.7 | 6.4 | 5.8 |
UK HPI3 | 2.4 | 2.3 | 5.0 |
UK bank rate | - | (0.1) | - |
US GDP1 | 3.9 | 3.1 | 2.9 |
US unemployment4 | 6.9 | 5.7 | 5.6 |
US HPI5 | 2.8 | 4.7 | 4.7 |
US federal funds rate | 0.3 | 0.3 | 0.3 |
Baseline average macroeconomic variables refreshed for sensitivity analysis | |||
Sensitivity analysis was performed by considering a refreshed Q121 baseline scenario relative to the rolled forward baseline scenario against material portfolios, using the macroeconomic variables in the table below. | |||
2021 | 2022 | 2023 | |
As at 31.03.21 | % | % | % |
UK GDP1 | 5.0 | 5.7 | 2.3 |
UK unemployment2 | 5.8 | 5.6 | 5.1 |
UK HPI3 | (0.5) | 0.3 | 3.6 |
UK bank rate | 0.1 | 0.3 | 0.4 |
US GDP1 | 5.5 | 3.8 | 1.6 |
US unemployment4 | 5.7 | 4.5 | 4.5 |
US HPI5 | 3.9 | 3.5 | 3.5 |
US federal funds rate | 0.3 | 0.3 | 0.7 |
1 | Average Real GDP seasonally adjusted change in year. |
2 | Average UK unemployment rate 16-year+. |
3 | Change in year-end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end. |
4 | Average US civilian unemployment rate 16-year+. |
5 | Change in year-end US HPI = FHFA house price index, relative to prior year end. |
Scenario probability weighting | |||||
Upside 2 | Upside 1 | Baseline | Downside 1 | Downside 2 | |
% | % | % | % | % | |
As at 31.03.21 | |||||
Scenario probability weighting | 20.2 | 24.2 | 24.7 | 15.5 | 15.4 |
As at 31.12.20 | |||||
Scenario probability weighting | 20.2 | 24.2 | 24.7 | 15.5 | 15.4 |
Treasury and Capital Risk
Capital
The Group's Overall Capital Requirement for CET1 is 11.1% comprising a 4.5% Pillar 1 minimum, a 2.5% Capital Conservation Buffer (CCB), a 1.5% Global Systemically Important Institution (G-SII) buffer, a 2.6% Pillar 2A requirement and a 0.0% Countercyclical Capital Buffer (CCyB).
The Group's CCyB is based on the buffer rate applicable for each jurisdiction in which the Group has exposures. On 11 March 2020, the Financial Policy Committee (FPC) set the CCyB rate for UK exposures at 0% with immediate effect. The buffer rates set by other national authorities for non-UK exposures are not currently material. Overall, this results in a 0.0% CCyB for the Group.
The Group's Pillar 2A requirement as per the Prudential Regulation Authority's (PRA) Individual Capital Requirement is 4.7% of which at least 56.25% needs to be met with CET1 capital, equating to approximately 2.6% of RWAs. The Pillar 2A requirement is subject to at least annual review and has been set as a nominal capital amount. This is based on a point in time assessment and the requirement (when expressed as a proportion of RWAs) will change depending on the total RWAs at each reporting period.
Following the withdrawal of the UK from the EU, any references to CRR as amended by CRR II mean, unless otherwise specified, CRR as amended by CRR II, as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018 and subject to the temporary transitional powers (TTP) available to UK regulators to delay or phase-in on-shoring changes to UK regulatory requirements arising at the end of the transition period until 31 March 2022, as at the applicable reporting date. Throughout the TTP period, the Bank of England (BoE) and PRA are expected to review the UK legislation framework and any disclosures made by the Group will be subject to any resulting guidance.
On 12 February 2021, the PRA launched a consultation on certain items within the Basel standards that remain to be implemented in the UK as well as setting out proposed new PRA CRR rules. The proposals include reverting to the previous treatment of 100% CET1 capital deduction for qualifying software assets by the end of 2021, meaning the c.40bps benefit in the CET1 ratio is likely to be reversed in future periods.
Capital ratios1,2,3 | As at | As at |
31.03.21 | 31.12.20 | |
CET1 | 14.6% | 15.1% |
Tier 1 (T1) | 18.4% | 19.0% |
Total regulatory capital | 21.8% | 22.1% |
| ||
Capital resources | £m | £m |
Total equity excluding non-controlling interests per the balance sheet | 65,105 | 65,797 |
Less: other equity instruments (recognised as AT1 capital) | (11,179) | (11,172) |
Adjustment to retained earnings for foreseeable ordinary share dividends | (303) | (174) |
Adjustment to retained earnings for foreseeable repurchase of shares | (439) | - |
Adjustment to retained earnings for foreseeable other equity coupons | (42) | (30) |
Other regulatory adjustments and deductions | ||
Additional value adjustments (PVA) | (1,496) | (1,146) |
Goodwill and intangible assets | (6,504) | (6,914) |
Deferred tax assets that rely on future profitability excluding temporary differences | (629) | (595) |
Fair value reserves related to gains or losses on cash flow hedges | (850) | (1,575) |
Gains or losses on liabilities at fair value resulting from own credit | 1,202 | 870 |
Defined benefit pension fund assets | (1,192) | (1,326) |
Direct and indirect holdings by an institution of own CET1 instruments | (50) | (50) |
Adjustment under IFRS 9 transitional arrangements | 2,285 | 2,556 |
Other regulatory adjustments | (4) | 55 |
CET1 capital | 45,904 | 46,296 |
| ||
AT1 capital | ||
Capital instruments and related share premium accounts | 11,179 | 11,172 |
Qualifying AT1 capital (including minority interests) issued by subsidiaries | 655 | 646 |
Other regulatory adjustments and deductions | (80) | (80) |
AT1 capital | 11,754 | 11,738 |
T1 capital | 57,658 | 58,034 |
| ||
T2 capital | ||
Capital instruments and related share premium accounts | 8,951 | 7,836 |
Qualifying T2 capital (including minority interests) issued by subsidiaries | 1,641 | 1,893 |
Credit risk adjustments (excess of impairment over expected losses) | 95 | 57 |
Other regulatory adjustments and deductions | (160) | (160) |
Total regulatory capital | 68,185 | 67,660 |
Total RWAs | 313,356 | 306,203 |
1 | CET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II. This includes IFRS 9 transitional arrangements and the grandfathering of CRR and CRR II non-compliant capital instruments. |
2 | The fully loaded CET1 ratio, as is relevant for assessing against the conversion trigger in Barclays PLC AT1 securities, was 14.0%, with £43.6bn of CET1 capital and £312.6bn of RWAs calculated without applying the transitional arrangements of the CRR as amended by CRR II. |
3 | The Group's CET1 ratio, as is relevant for assessing against the conversion trigger in Barclays Bank PLC 7.625% Contingent Capital Notes, was 14.6%. For this calculation CET1 capital and RWAs are calculated applying the transitional arrangements under the CRR as amended by CRR II, including the IFRS 9 transitional arrangements. The benefit of the Financial Services Authority (FSA) October 2012 interpretation of the transitional provisions, relating to the implementation of CRD IV, expired in December 2017. |
Movement in CET1 capital | Three months |
ended | |
31.03.21 | |
£m | |
Opening CET1 capital | 46,296 |
Profit for the period attributable to equity holders | 1,899 |
Own credit relating to derivative liabilities | 14 |
Ordinary share dividends paid and foreseen | (129) |
Purchased and foreseeable share repurchase | (700) |
Other equity coupons paid and foreseen | (207) |
Increase in retained regulatory capital generated from earnings | 877 |
Net impact of share schemes | (167) |
Fair value through other comprehensive income reserve | (320) |
Currency translation reserve | (478) |
Other reserves | (6) |
Decrease in other qualifying reserves | (971) |
Pension remeasurements within reserves | (186) |
Defined benefit pension fund asset deduction | 134 |
Net impact of pensions | (52) |
Additional value adjustments (PVA) | (350) |
Goodwill and intangible assets | 410 |
Deferred tax assets that rely on future profitability excluding those arising from temporary differences | (34) |
Adjustment under IFRS 9 transitional arrangements | (271) |
Other regulatory adjustments | (1) |
Decrease in regulatory capital due to adjustments and deductions | (246) |
Closing CET1 capital | 45,904 |
CET1 capital decreased £0.4bn to £45.9bn (December 2020: £46.3bn).
£1.9bn of capital generated from profits were partially offset by £1.0bn dividends paid and foreseen including £0.7bn for the share buyback announced with FY20 results, £0.2bn of equity coupons paid and a £0.1bn accrual towards a FY21 dividend. Other significant movements in the period were:
· | A £0.3bn reduction in the fair value through other comprehensive income reserve driven by movements in the valuation of the liquidity pool |
· | A £0.5bn decrease in the currency translation reserves due to the depreciation of period end EUR and USD against GBP |
· | A £0.4bn increase in the PVA deduction due to the removal of temporary regulatory supporting measures applied to certain additional valuation adjustments |
· | A £0.4bn decrease in the goodwill and intangible deduction reflecting new qualifying software intangibles that are subject to risk weighting rather than deduction |
· | A £0.3bn decrease in IFRS 9 transitional relief, after tax, primarily due to the amount of relief applied to the pre-2020 impairment charge reducing to 50% in 2021 from 70% in 2020 |
RWAs by risk type and business | |||||||||||||
Credit risk | Counterparty credit risk | Market risk | Operational risk | Total RWAs | |||||||||
Std | IRB | Std | IRB | Settlement risk | CVA | Std | IMA | ||||||
As at 31.03.21 | £m | £m | £m | £m | £m | £m | £m | £m | £m | £m | |||
Barclays UK | 7,066 | 53,512 | 431 | - | - | 217 | 64 | - | 11,381 | 72,671 | |||
Corporate and Investment Bank | 25,832 | 75,854 | 13,781 | 19,218 | 102 | 2,452 | 16,479 | 24,083 | 23,452 | 201,253 | |||
Consumer, Cards and Payments | 18,621 | 2,875 | 178 | 41 | - | 28 | - | 59 | 6,949 | 28,751 | |||
Barclays International | 44,453 | 78,729 | 13,959 | 19,259 | 102 | 2,480 | 16,479 | 24,142 | 30,401 | 230,004 | |||
Head Office | 4,424 | 7,065 | - | - | - | - | - | - | (808) | 10,681 | |||
Barclays Group | 55,943 | 139,306 | 14,390 | 19,259 | 102 | 2,697 | 16,543 | 24,142 | 40,974 | 313,356 | |||
As at 31.12.20 | |||||||||||||
Barclays UK | 7,360 | 54,340 | 394 | - | - | 136 | 72 | - | 11,359 | 73,661 | |||
Corporate and Investment Bank | 24,660 | 73,792 | 12,047 | 20,280 | 246 | 2,351 | 13,123 | 22,363 | 23,343 | 192,205 | |||
Consumer, Cards and Payments | 19,754 | 3,041 | 177 | 45 | - | 31 | - | 71 | 6,996 | 30,115 | |||
Barclays International | 44,414 | 76,833 | 12,224 | 20,325 | 246 | 2,382 | 13,123 | 22,434 | 30,339 | 222,320 | |||
Head Office | 4,153 | 6,869 | - | - | - | - | - | - | (800) | 10,222 | |||
Barclays Group | 55,927 | 138,042 | 12,618 | 20,325 | 246 | 2,518 | 13,195 | 22,434 | 40,898 | 306,203 | |||
Movement analysis of RWAs | |||||
Credit risk | Counterparty credit risk | Market risk | Operational risk | Total RWAs | |
£m | £m | £m | £m | £m | |
Opening RWAs (as at 31.12.20) | 193,969 | 35,707 | 35,629 | 40,898 | 306,203 |
Book size | 2,971 | 691 | 5,056 | 76 | 8,794 |
Acquisitions and disposals | (59) | - | - | - | (59) |
Book quality | 628 | 213 | - | - | 841 |
Model updates | (438) | (163) | - | - | (601) |
Methodology and policy | (115) | - | - | - | (115) |
Foreign exchange movements1 | (1,707) | - | - | - | (1,707) |
Total RWA movements | 1,280 | 741 | 5,056 | 76 | 7,153 |
Closing RWAs (as at 31.03.21) | 195,249 | 36,448 | 40,685 | 40,974 | 313,356 |
1 | Foreign exchange movements do not include foreign exchange for counterparty credit risk or market risk. |
Overall RWAs increased £7.2bn to £313.4bn (December 2020: £306.2bn). Significant movements in the period were:
Credit risk RWAs increased £1.3bn:
· | A £3.0bn increase in book size primarily due to increased CIB lending, growth in mortgages within Barclays UK partially offset by lower consumer lending and ESHLA |
· | A £1.7bn decrease due to the depreciation of period end EUR and USD against GBP |
Market risk RWAs increased £5.1bn:
· | A £5.1bn increase in book size primarily due to increased client and trading activity |
Leverage ratio and exposures
The Group is subject to a leverage ratio requirement of 3.8% as at 31 March 2021. This comprises the 3.25% minimum requirement, a G-SII additional leverage ratio buffer (G-SII ALRB) of 0.53% and a countercyclical leverage ratio buffer of 0.0%. Although the leverage ratio is expressed in terms of T1 capital, 75% of the minimum requirement, equating to 2.4375%, needs to be met with CET1 capital. In addition, the G-SII ALRB must be covered solely with CET1 capital. The CET1 capital held against the 0.53% G-SII ALRB was £6.2bn.
The Group is required to disclose an average UK leverage ratio which is based on capital on the last day of each month in the quarter and an exposure measure for each day in the quarter. The Group is also required to disclose a UK leverage ratio based on capital and exposure on the last day of the quarter. Both approaches exclude qualifying claims on central banks from the leverage exposures and include the PRA's early adoption of CRR II settlement netting. The FPC intends to review the UK leverage framework in 2021.
Leverage ratios1,2 | As at 31.03.21 | As at 31.12.20 |
£m | £m | |
Average UK leverage ratio | 4.9% | 5.0% |
Average T1 capital3 | 57,040 | 57,069 |
Average UK leverage exposure | 1,174,887 | 1,146,919 |
UK leverage ratio | 5.0% | 5.3% |
CET1 capital | 45,904 | 46,296 |
AT1 capital | 11,099 | 11,092 |
T1 capital3 | 57,003 | 57,388 |
UK leverage exposure | 1,145,413 | 1,090,907 |
UK leverage exposure | ||
Accounting assets | ||
Derivative financial instruments | 270,717 | 302,446 |
Derivative cash collateral | 51,797 | 64,798 |
Securities financing transactions (SFTs) | 189,496 | 164,034 |
Loans and advances and other assets | 867,646 | 818,236 |
Total IFRS assets | 1,379,656 | 1,349,514 |
Regulatory consolidation adjustments | (1,926) | (1,144) |
Derivatives adjustments | ||
Derivatives netting | (242,857) | (272,275) |
Adjustments to cash collateral | (45,464) | (57,414) |
Net written credit protection | 16,814 | 14,986 |
Potential future exposure (PFE) on derivatives | 128,454 | 117,010 |
Total derivatives adjustments | (143,053) | (197,693) |
SFTs adjustments | 22,294 | 21,114 |
Regulatory deductions and other adjustments | (18,111) | (17,469) |
Weighted off-balance sheet commitments | 118,134 | 113,704 |
Qualifying central bank claims | (167,054) | (155,890) |
Settlement netting | (44,527) | (21,229) |
UK leverage exposure | 1,145,413 | 1,090,907 |
1 | Fully loaded average UK leverage ratio was 4.7%, with £54.8bn of T1 capital and £1,173bn of leverage exposure. Fully loaded UK leverage ratio was 4.8%, with £54.7bn of T1 capital and £1,143bn of leverage exposure. Fully loaded UK leverage ratios are calculated without applying the transitional arrangements of the CRR as amended by CRR II. |
2 | Capital and leverage measures are calculated applying the transitional arrangements of the CRR as amended by CRR II. |
3 | T1 capital is calculated in line with the PRA Handbook. |
The average UK leverage ratio decreased to 4.9% (December 2020: 5.0%). The average leverage exposure increased by £28bn to £1,175bn (December 2020: £1,147bn) largely driven by an increase in securities financing transactions (SFTs).
The UK leverage ratio decreased to 5.0% (December 2020: 5.3%). The UK leverage exposure increased by £54.5bn to £1,145bn (December 2020: £1,091bn) primarily driven by:
· | A £25.5bn increase in SFTs; and |
· | A £11.4bn increase in PFE on derivatives driven by increased trading activity |
The Group also discloses a CRR leverage ratio1 within its additional regulatory disclosures prepared in accordance with EBA guidelines on disclosure under Part Eight of the CRR (see Barclays PLC Pillar 3 Report Q1 2021, due to be published on 30 April 2021 and which will be available at home.barclays/investor-relations/reports-and-events/latest-financial-results).
1 | CRR leverage ratio as amended by CRR II. |
MREL
The Group is required to meet the higher of: (i) the requirements set by the BoE based on RWAs and the higher of average and UK leverage exposures; and (ii) the requirements in CRR as amended by CRR II based on RWAs and CRR leverage exposures. The MREL requirements are subject to phased implementation and will be fully implemented by 1 January 2022.
As at 31 March 2021, the Group's MREL requirement was to meet 7.0% of CRR leverage exposures. On 19 January 2021 the BoE published indicative MREL requirements that show the Group's highest requirement in 2022 will be 7.7% of CRR leverage exposure, based on 30 September 2020 exposures. The BoE is currently reviewing the MREL calibration and intends to make any policy changes by the end of 2021. Separately, the FPC intends to review the UK leverage framework in 2021 and this, along with any MREL policy changes, may result in a different MREL requirement from 1 January 2022 than that which is currently proposed. CET1 capital cannot be counted towards both MREL and the capital buffers, meaning that the buffers will effectively be applied above MREL requirements.
Own funds and eligible liabilities ratios1,2 | As a percentage of RWAs | As a percentage of CRR leverage exposure | |||
As at 31.03.21 | As at 31.12.20 | As at 31.03.21 | As at 31.12.20 | ||
Total Barclays PLC (the Parent company) own funds and eligible liabilities | 32.1% | 32.7% | 7.6% | 8.0% | |
Total own funds and eligible liabilities, including eligible Barclays Bank PLC instruments3 | 32.8% | 33.6% | 7.8% | 8.2% | |
Own funds and eligible liabilities1,2 | As at 31.03.21 | As at 31.12.20 | |||
£m | £m | ||||
CET1 capital | 45,904 | 46,296 | |||
AT1 capital instruments and related share premium accounts4 | 11,099 | 11,092 | |||
T2 capital instruments and related share premium accounts4 | 8,886 | 7,733 | |||
Eligible liabilities | 34,571 | 35,086 | |||
Total Barclays PLC (the Parent company) own funds and eligible liabilities | 100,460 | 100,207 | |||
Qualifying AT1 capital (including minority interests) issued by subsidiaries | 655 | 646 | |||
Qualifying T2 capital (including minority interests) issued by subsidiaries | 1,641 | 1,893 | |||
Total own funds and eligible liabilities, including eligible Barclays Bank PLC instruments3 | 102,756 | 102,746 | |||
Total RWAs | 313,356 | 306,203 | |||
Total CRR leverage exposure5 | 1,320,628 | 1,254,157 | |||
1 | CET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II. This includes IFRS 9 transitional arrangements and the grandfathering of CRR and CRR II non-compliant capital instruments. |
2 | The BoE has set external MREL based on the higher of RWAs and CRR or UK leverage exposures which could result in the binding measure changing in future periods. The 31 March 2021 Barclays PLC (the Parent company) own funds and eligible liabilities ratio as a percentage of the UK leverage exposure was 8.8% and as a percentage of the average UK leverage exposure was 8.6%. |
3 | Own funds instruments issued by subsidiaries will not be counted towards MREL from 1 January 2022. |
4 | Includes other AT1 capital regulatory adjustments and deductions of £80m (December 2020: £80m), and other T2 credit risk adjustments and deductions of £65m (December 2020: £103m). |
5 | Fully loaded CRR leverage exposure is calculated without applying the transitional arrangements of the CRR as amended by CRR II. |
Condensed Consolidated Financial Statements
Condensed consolidated income statement | |||
Three months ended | Three months ended | ||
31.03.21 | 31.03.20 | ||
£m | £m | ||
Total income | 5,900 | 6,283 | |
Credit impairment charges | (55) | (2,115) | |
Net operating income | 5,845 | 4,168 | |
Operating expenses excluding litigation and conduct | (3,545) | (3,253) | |
Litigation and conduct | (33) | (10) | |
Operating expenses | (3,578) | (3,263) | |
Other net income | 132 | 8 | |
Profit before tax | 2,399 | 913 | |
Tax charge | (496) | (71) | |
Profit after tax | 1,903 | 842 | |
Attributable to: | |||
Equity holders of the parent | 1,704 | 605 | |
Other equity instrument holders | 195 | 221 | |
Total equity holders of the parent | 1,899 | 826 | |
Non-controlling interests | 4 | 16 | |
Profit after tax | 1,903 | 842 | |
Earnings per share | p | p | |
Basic earnings per ordinary share | 9.9 | 3.5 | |
Condensed consolidated balance sheet | |||
As at | As at | ||
31.03.21 | 31.12.20 | ||
Assets | £m | £m | |
Cash and balances at central banks | 209,521 | 191,127 | |
Cash collateral and settlement balances | 112,662 | 101,367 | |
Loans and advances at amortised cost | 345,778 | 342,632 | |
Reverse repurchase agreements and other similar secured lending | 10,276 | 9,031 | |
Trading portfolio assets | 131,226 | 127,950 | |
Financial assets at fair value through the income statement | 201,610 | 175,151 | |
Derivative financial instruments | 270,717 | 302,446 | |
Financial assets at fair value through other comprehensive income | 74,680 | 78,688 | |
Investments in associates and joint ventures | 917 | 781 | |
Goodwill and intangible assets | 7,867 | 7,948 | |
Current tax assets | 170 | 477 | |
Deferred tax assets | 4,053 | 3,444 | |
Other assets | 10,179 | 8,472 | |
Total assets | 1,379,656 | 1,349,514 | |
Liabilities | |||
Deposits at amortised cost | 498,752 | 481,036 | |
Cash collateral and settlement balances | 107,130 | 85,423 | |
Repurchase agreements and other similar secured borrowing | 20,949 | 14,174 | |
Debt securities in issue | 87,291 | 75,796 | |
Subordinated liabilities | 15,944 | 16,341 | |
Trading portfolio liabilities | 60,735 | 47,405 | |
Financial liabilities designated at fair value | 249,852 | 249,765 | |
Derivative financial instruments | 260,407 | 300,775 | |
Current tax liabilities | 768 | 645 | |
Deferred tax liabilities | 15 | 15 | |
Other liabilities | 11,644 | 11,257 | |
Total liabilities | 1,313,487 | 1,282,632 | |
Equity | |||
Called up share capital and share premium | 4,619 | 4,637 | |
Other reserves | 2,648 | 4,461 | |
Retained earnings | 46,659 | 45,527 | |
Shareholders' equity attributable to ordinary shareholders of the parent | 53,926 | 54,625 | |
Other equity instruments | 11,179 | 11,172 | |
Total equity excluding non-controlling interests | 65,105 | 65,797 | |
Non-controlling interests | 1,064 | 1,085 | |
Total equity | 66,169 | 66,882 | |
Total liabilities and equity | 1,379,656 | 1,349,514 | |
Condensed consolidated statement of changes in equity | |||||||
Called up share capital and share premium | Other equity instruments | Other reserves | Retained earnings | Total | Non-controlling interests | Total equity | |
Three months ended 31.03.21 | £m | £m | £m | £m | £m | £m | £m |
Balance as at 1 January 2021 | 4,637 | 11,172 | 4,461 | 45,527 | 65,797 | 1,085 | 66,882 |
Profit after tax | - | 195 | - | 1,704 | 1,899 | 4 | 1,903 |
Retirement benefit remeasurements | - | - | - | (186) | (186) | - | (186) |
Other | - | - | (1,842) | - | (1,842) | - | (1,842) |
Total comprehensive income for the period | - | 195 | (1,842) | 1,518 | (129) | 4 | (125) |
Equity settled share schemes and hedges thereof | 9 | - | - | 266 | 275 | - | 275 |
Other equity instruments coupons paid | - | (195) | - | - | (195) | - | (195) |
Vesting of shares under employee share schemes | - | - | 2 | (386) | (384) | - | (384) |
Repurchase of shares | (27) | - | 27 | (261) | (261) | - | (261) |
Dividends paid | - | - | - | - | - | (1) | (1) |
Other movements | - | 7 | - | (5) | 2 | (24) | (22) |
Balance as at 31 March 2021 | 4,619 | 11,179 | 2,648 | 46,659 | 65,105 | 1,064 | 66,169 |
As at | As at | |
31.03.21 | 31.12.20 | |
Other reserves | £m | £m |
Currency translation reserve | 2,393 | 2,871 |
Fair value through other comprehensive income reserve | (315) | 5 |
Cash flow hedging reserve | 849 | 1,575 |
Own credit reserve | (1,272) | (954) |
Other reserves and treasury shares | 993 | 964 |
Total | 2,648 | 4,461 |
Basis of preparation
The condensed consolidated financial statements are prepared in accordance with the recognition and measurement requirements of UK-adopted international accounting standards (UK-adopted International Financial Reporting Standards). Following the UK's departure from the European Union (EU) at the end of the Brexit transition period on 31 December 2020, all EU endorsed IFRS became UK-adopted IFRS. On 6 January 2021, the UK endorsed the phase 2 amendments to IFRS 9 and IAS 39 in respect of interest rate benchmark reform, which was also endorsed by the EU on 13 January 2021 and were early adopted in the Barclays PLC 2020 Annual Report. UK adopted IFRS and EU endorsed IFRS are currently the same.
Appendix: Non-IFRS Performance Measures
The Group's management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses' performance between financial periods, and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by management.
However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well.
Non-IFRS performance measures glossary
Measure | Definition |
Loan: deposit ratio | Loans and advances at amortised cost divided by deposits at amortised cost. |
Period end allocated tangible equity | Allocated tangible equity is calculated as 13.5% (2020: 13.0%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office allocated tangible equity represents the difference between the Group's tangible shareholders' equity and the amounts allocated to businesses. |
Average tangible shareholders' equity | Calculated as the average of the previous month's period end tangible equity and the current month's period end tangible equity. The average tangible shareholders' equity for the period is the average of the monthly averages within that period. |
Average allocated tangible equity | Calculated as the average of the previous month's period end allocated tangible equity and the current month's period end allocated tangible equity. The average allocated tangible equity for the period is the average of the monthly averages within that period. |
Return on average tangible shareholders' equity | Annualised profit after tax attributable to ordinary equity holders of the parent, as a proportion of average shareholders' equity excluding non-controlling interests and other equity instruments adjusted for the deduction of intangible assets and goodwill. The components of the calculation have been included on page 32 to 33. |
Return on average allocated tangible equity | Annualised profit after tax attributable to ordinary equity holders of the parent, as a proportion of average allocated tangible equity. The components of the calculation have been included on page 32 to 34. |
Cost: income ratio | Total operating expenses divided by total income. |
Loan loss rate | Quoted in basis points and represents total annualised impairment charges divided by gross loans and advances held at amortised cost at the balance sheet date. The components of the calculation have been included on page 16. |
Net interest margin | Annualised net interest income divided by the sum of average customer assets. The components of the calculation have been included on page 15. |
Tangible net asset value per share | Calculated by dividing shareholders' equity, excluding non-controlling interests and other equity instruments, less goodwill and intangible assets, by the number of issued ordinary shares. The components of the calculation have been included on page 34. |
Pre-provision profits | Calculated by excluding credit impairment charges from profit before tax. The components of the calculation have been included on page 33. |
Returns
Return on average tangible equity is calculated as profit after tax attributable to ordinary equity holders of the parent as a proportion of average tangible equity, excluding non-controlling and other equity interests for businesses. Allocated tangible equity has been calculated as 13.5% (2020: 13.0%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office average allocated tangible equity represents the difference between the Group's average tangible shareholders' equity and the amounts allocated to businesses.
Profit/(loss) attributable to ordinary equity holders of the parent | Average tangible equity | Return on average tangible equity | |||
Three months ended 31.03.21 | £m | £bn | % | ||
Barclays UK | 298 | 9.9 | 12.0 | ||
Corporate and Investment Bank | 1,263 | 28.2 | 17.9 | ||
Consumer, Cards and Payments | 168 | 4.1 | 16.5 | ||
Barclays International | 1,431 | 32.3 | 17.7 | ||
Head Office | (25) | 4.3 | n/m | ||
Barclays Group | 1,704 | 46.5 | 14.7 | ||
Three months ended 31.03.20 | |||||
Barclays UK | 175 | 10.1 | 6.9 | ||
Corporate and Investment Bank | 820 | 26.2 | 12.5 | ||
Consumer, Cards and Payments | (291) | 5.0 | (23.5) | ||
Barclays International | 529 | 31.2 | 6.8 | ||
Head Office | (99) | 5.6 | n/m | ||
Barclays Group | 605 | 47.0 | 5.1 |
Barclays Group | ||||||||||
Q121 | Q420 | Q320 | Q220 | Q120 | Q419 | Q319 | Q219 | |||
Return on average tangible shareholders' equity | £m | £m | £m | £m | £m | £m | £m | £m | ||
Attributable profit/(loss) | 1,704 | 220 | 611 | 90 | 605 | 681 | (292) | 1,034 | ||
£bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | |||
Average shareholders' equity | 54.4 | 55.7 | 56.4 | 58.4 | 55.2 | 54.5 | 56.4 | 54.0 | ||
Average goodwill and intangibles | (7.9) | (8.1) | (8.1) | (8.2) | (8.2) | (8.1) | (8.0) | (7.8) | ||
Average tangible shareholders' equity | 46.5 | 47.6 | 48.3 | 50.2 | 47.0 | 46.4 | 48.4 | 46.2 | ||
Return on average tangible shareholders' equity | 14.7% | 1.8% | 5.1% | 0.7% | 5.1% | 5.9% | (2.4%) | 9.0% | ||
Pre-provision profits | ||||||||||
Profit before tax excluding credit impairment charges | Q121 | Q420 | Q320 | Q220 | Q120 | Q419 | Q319 | Q219 | ||
£m | £m | £m | £m | £m | £m | £m | £m | |||
Profit before tax | 2,399 | 646 | 1,147 | 359 | 913 | 1,097 | 246 | 1,531 | ||
Impact of credit impairment charges | 55 | 492 | 608 | 1,623 | 2,115 | 523 | 461 | 480 | ||
Profit before tax excluding credit impairment charges | 2,454 | 1,138 | 1,755 | 1,982 | 3,028 | 1,620 | 707 | 2,011 |
Barclays UK | ||||||||||
Q121 | Q420 | Q320 | Q220 | Q120 | Q419 | Q319 | Q219 | |||
Return on average allocated tangible equity | £m | £m | £m | £m | £m | £m | £m | £m | ||
Attributable profit/(loss) | 298 | 160 | 113 | (123) | 175 | 438 | (907) | 328 | ||
£bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | |||
Average allocated equity | 13.5 | 13.4 | 13.7 | 13.9 | 13.7 | 13.8 | 13.9 | 13.8 | ||
Average goodwill and intangibles | (3.6) | (3.6) | (3.6) | (3.6) | (3.6) | (3.5) | (3.5) | (3.5) | ||
Average allocated tangible equity | 9.9 | 9.8 | 10.1 | 10.3 | 10.1 | 10.3 | 10.4 | 10.3 | ||
Return on average allocated tangible equity | 12.0% | 6.5% | 4.5% | (4.8%) | 6.9% | 17.0% | (34.9%) | 12.7% | ||
Barclays International | ||||||||||
Q121 | Q420 | Q320 | Q220 | Q120 | Q419 | Q319 | Q219 | |||
Return on average allocated tangible equity | £m | £m | £m | £m | £m | £m | £m | £m | ||
Attributable profit | 1,431 | 441 | 782 | 468 | 529 | 397 | 799 | 832 | ||
£bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | |||
Average allocated equity | 32.8 | 31.1 | 31.2 | 34.2 | 31.9 | 31.9 | 33.3 | 32.1 | ||
Average goodwill and intangibles | (0.5) | (0.6) | (0.6) | (0.7) | (0.7) | (1.0) | (1.1) | (1.0) | ||
Average allocated tangible equity | 32.3 | 30.5 | 30.6 | 33.5 | 31.2 | 30.9 | 32.2 | 31.1 | ||
Return on average allocated tangible equity | 17.7% | 5.8% | 10.2% | 5.6% | 6.8% | 5.1% | 9.9% | 10.7% | ||
Corporate and Investment Bank | ||||||||||
Q121 | Q420 | Q320 | Q220 | Q120 | Q419 | Q319 | Q219 | |||
Return on average allocated tangible equity | £m | £m | £m | £m | £m | £m | £m | £m | ||
Attributable profit | 1,263 | 413 | 627 | 694 | 820 | 193 | 609 | 596 | ||
£bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | |||
Average allocated equity | 28.2 | 26.3 | 26.4 | 29.1 | 26.2 | 25.9 | 26.9 | 25.8 | ||
Average goodwill and intangibles | - | - | - | (0.1) | - | (0.1) | - | - | ||
Average allocated tangible equity | 28.2 | 26.3 | 26.4 | 29.0 | 26.2 | 25.8 | 26.9 | 25.8 | ||
Return on average allocated tangible equity | 17.9% | 6.3% | 9.5% | 9.6% | 12.5% | 3.0% | 9.1% | 9.2% | ||
Consumer, Cards and Payments | ||||||||||
Q121 | Q420 | Q320 | Q220 | Q120 | Q419 | Q319 | Q219 | |||
Return on average allocated tangible equity | £m | £m | £m | £m | £m | £m | £m | £m | ||
Attributable profit/(loss) | 168 | 28 | 155 | (226) | (291) | 204 | 190 | 236 | ||
£bn | £bn | £bn | £bn | £bn | £bn | £bn | £bn | |||
Average allocated equity | 4.6 | 4.8 | 4.8 | 5.1 | 5.7 | 6.0 | 6.4 | 6.3 | ||
Average goodwill and intangibles | (0.5) | (0.6) | (0.6) | (0.6) | (0.7) | (0.9) | (1.1) | (1.0) | ||
Average allocated tangible equity | 4.1 | 4.2 | 4.2 | 4.5 | 5.0 | 5.1 | 5.3 | 5.3 | ||
Return on average allocated tangible equity | 16.5% | 2.7% | 14.7% | (20.2%) | (23.5%) | 15.9% | 14.2% | 17.8% | ||
Tangible net asset value per share | As at | As at | As at |
31.03.21 | 31.12.20 | 31.03.20 | |
£m | £m | £m | |
Total equity excluding non-controlling interests | 65,105 | 65,797 | 68,369 |
Other equity instruments | (11,179) | (11,172) | (10,871) |
Goodwill and intangibles | (7,867) | (7,948) | (8,209) |
Tangible shareholders' equity attributable to ordinary shareholders of the parent | 46,059 | 46,677 | 49,289 |
m | m | m | |
Shares in issue | 17,257 | 17,359 | 17,322 |
p | p | p | |
Tangible net asset value per share | 267 | 269 | 284 |
Shareholder Information
Results timetable1 | Date | |||||
2021 Interim Results Announcement | 28 July 2021 | |||||
% Change3 | ||||||
Exchange rates2 | 31.03.21 | 31.12.20 | 31.03.20 | 31.12.20 | 31.03.20 | |
Period end - USD/GBP | 1.38 | 1.37 | 1.24 | 1% | 11% | |
3 month average - USD/GBP | 1.38 | 1.32 | 1.28 | 5% | 8% | |
Period end - EUR/GBP | 1.18 | 1.12 | 1.13 | 5% | 4% | |
3 month average - EUR/GBP | 1.14 | 1.11 | 1.16 | 3% | (2%) | |
Share price data | ||||||
Barclays PLC (p) | 185.92 | 146.68 | 94.11 | |||
Barclays PLC number of shares (m) | 17,223 | 17,359 | 17,332 | |||
For further information please contact | ||||||
Investor relations | Media relations | |||||
Chris Manners +44 (0) 20 7773 2136 | Tom Hoskin +44 (0) 20 7116 4755 | |||||
More information on Barclays can be found on our website: home.barclays. | ||||||
Registered office | ||||||
1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839. | ||||||
Registrar | ||||||
Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA, United Kingdom. | ||||||
Tel: 0371 384 20554 from the UK or +44 121 415 7004 from overseas. | ||||||
American Depositary Receipts (ADRs) | ||||||
Shareowner Services | ||||||
Tel: +1 800 990 1135 (toll free in US and Canada), +1 651 453 2128 (outside the US and Canada) | ||||||
Shareowner Services, PO Box 64504, St Paul, MN 55164-0504, USA. | ||||||
Delivery of ADR certificates and overnight mail | ||||||
Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120, USA. | ||||||
1 | Note that these dates are provisional and subject to change. |
2 | The average rates shown above are derived from daily spot rates during the year. |
3 | The change is the impact to GBP reported information. |
4 | Lines open 8.30am to 5.30pm (UK time), Monday to Friday, excluding UK public holidays in England and Wales. |
Notes
The terms Barclays or Group refer to Barclays PLC together with its subsidiaries. Unless otherwise stated, the income statement analysis compares the three months ended 31 March 2021 to the corresponding three months of 2020 and balance sheet analysis as at 31 March 2021 with comparatives relating to 31 December 2020 and 31 March 2020. The abbreviations '£m' and '£bn' represent millions and thousands of millions of Pounds Sterling respectively; the abbreviations '$m', '$bn' and '$trn' represent millions, thousands of millions and thousands of billions of US Dollars respectively; and the abbreviations '€m' and '€bn' represent millions and thousands of millions of Euros respectively.
There are a number of key judgement areas, for example impairment calculations, which are based on models and which are subject to ongoing adjustment and modifications. Reported numbers reflect best estimates and judgements at the given point in time.
Relevant terms that are used in this document but are not defined under applicable regulatory guidance or International Financial Reporting Standards (IFRS) are explained in the results glossary that can be accessed at home.barclays/investor-relations/reports-and-events/latest-financial-results.
The information in this announcement, which was approved by the Board of Directors on 29 April 2021, does not comprise statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2020, which contain an unmodified audit report under Section 495 of the Companies Act 2006 (which did not make any statements under Section 498 of the Companies Act 2006) will be delivered to the Registrar of Companies in accordance with Section 441 of the Companies Act 2006.
These results will be furnished on Form 6-K with the US Securities and Exchange Commission (SEC) as soon as practicable following their publication. Once furnished with the SEC, a copy of the Form 6-K will be available from the SEC's website at www.sec.gov.
Barclays is a frequent issuer in the debt capital markets and regularly meets with investors via formal road-shows and other ad hoc meetings. Consistent with its usual practice, Barclays expects that from time to time over the coming quarter it will meet with investors globally to discuss these results and other matters relating to the Group.
Non-IFRS performance measures
Barclays' management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses' performance between financial periods and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by Barclays' management. However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well. Refer to the appendix on pages 31 to 34 for further information and calculations of non-IFRS performance measures included throughout this document, and the most directly comparable IFRS measures.
Forward-looking statements
This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in the forward-looking statements. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as 'may', 'will', 'seek', 'continue', 'aim', 'anticipate', 'target', 'projected', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', 'achieve' or other words of similar meaning. Forward-looking statements can be made in writing but also may be made verbally by members of the management of the Group (including, without limitation, during management presentations to financial analysts) in connection with this document. Examples of forward-looking statements include, among others, statements or guidance regarding or relating to the Group's future financial position, income growth, assets, impairment charges, provisions, business strategy, capital, leverage and other regulatory ratios, capital distributions (including dividend pay-out ratios and expected payment strategies), projected levels of growth in the banking and financial markets, projected costs or savings, any commitments and targets, estimates of capital expenditures, plans and objectives for future operations, projected employee numbers, IFRS impacts and other statements that are not historical fact. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. The forward-looking statements speak only as at the date on which they are made. Forward-looking statements may be affected by: changes in legislation; the development of standards and interpretations under IFRS, including evolving practices with regard to the interpretation and application of accounting and regulatory standards; the outcome of current and future legal proceedings and regulatory investigations; future levels of conduct provisions; the policies and actions of governmental and regulatory authorities; the Group's ability along with government and other stakeholders to manage and mitigate the impacts of climate change effectively; geopolitical risks; and the impact of competition. In addition, factors including (but not limited to) the following may have an effect: capital, leverage and other regulatory rules applicable to past, current and future periods; UK, US, Eurozone and global macroeconomic and business conditions; the effects of any volatility in credit markets; market related risks such as changes in interest rates and foreign exchange rates; effects of changes in valuation of credit market exposures; changes in valuation of issued securities; volatility in capital markets; changes in credit ratings of any entity within the Group or any securities issued by such entities; direct and indirect impacts of the coronavirus (COVID-19) pandemic; instability as a result of the UK's exit from the European Union (EU), the effects of the EU-UK Trade and Cooperation Agreement and the disruption that may subsequently result in the UK and globally; the risk of cyber-attacks, information or security breaches or technology failures on the Group's business or operations; and the success of future acquisitions, disposals and other strategic transactions. A number of these influences and factors are beyond the Group's control. As a result, the Group's actual financial position, future results, capital distributions, capital, leverage or other regulatory ratios or other financial and non-financial metrics or performance measures may differ materially from the statements or guidance set forth in the Group's forward-looking statements. Additional risks and factors which may impact the Group's future financial condition and performance are identified in our filings with the SEC (including, without limitation, our Annual Report on Form 20-F for the fiscal year ended 31 December 2020), which are available on the SEC's website at www.sec.gov.
Subject to our obligations under the applicable laws and regulations of any relevant jurisdiction, (including, without limitation, the UK and the US), in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Related Shares:
Barclays